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PART ONE: REVIEW OF THE LITERATURE

Foreword
Antibiotics and antibacterials can be classified based upon how they are produced.
Compounds referred to as true antibiotics are products of one microorganism that inhibit
the growth of another microorganism, while compounds referred to as antibacterials may
have the same activity, but are usually produced synthetically. Antibacterials may be
simple chemical alterations of an antibiotic, as in the case of tetracycline, or they may be
entirely synthetic, as in the case of fluoroquinolones. In terms of their systemic use in
animals, both types of compounds are used in the same fashion, thus the difference is
mainly one of semantics. As such, unless specified, the term antibacterial and antibiotic
will often be used interchangeably.
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Introduction
Coinciding with the discovery of antibiotics as effective growth promatants in the
l 950's was the elucidation that bacteria, when exposed to an antibiotic, develop several
resourceful means to evade the lethal effects of the drugs (for review see 64, 45, 87, 119).
It follows that among the more controversial agricultural practices in the United States is
the use of antibiotics for growth promotion and prophylaxis in livestock production.
There is little consensus, however, as to the risks this use of antibiotics may pose to
human health with producers, health care professionals, pharamaceutical companies,
consumers and even those conducting research in the field often having very different
opinions [6, 68, 71].
Through 50 years of research, several of the ecological factors and genetic
mechanisms involved in bacterial

drug resistance acquisition have been

well

characterized. It is now agreed that the majority of methods by which a bacterial cell
becomes resistant to a drug involve the acquisition of exogenous DNA whose
corresponding protein confers resistance to the cell in some manner (for review see [5 ,
45, 87, 119]).
In recent years, many different and diverse genes responsible for antibiotic
resistance have been found flanked by similar DNA sequences.

These similar DNA

sequences are now recognized as integrons; mechanisms employed by bacteria in the
incorporation of foreign DNA. More specificall y, integrons are gene capturing systems
that aid in the acquisition of drug resistance by overseeing the site specific recombination
of antibiotic resistance gene cassettes into the bacterial genome.

3

Over the past 10 years, integron or integron-Jike genetic structures have been
found in several diverse genera of gram-negative bacteria and recently in several gram
positive genera (for review see [17, 20, 36, 48 , 49, 65 , 88, 103]. Moreover, in many
cases, integron-mediated gene integration has been implicated in the development of
multiple-drug resi stant phenotypes in strains of pathogenic bacteria associated with both
humans and animals [7, 11, 72, 100, 134] .
A large amount of the research regarding integron-mediated antibiotic resistance
has been conducted by agricultural scientists [7 , 14, 72, 85, 108, 115, 134] . The major
impetus for this research has been the development and dissemination of Salmonella

enterica var Typhimurium DT104 (DT104). Isolates of DT104 strain regularly exhibit a
core

penta-drug

resistant

phenotype

(ampicillin,

chloramphenicol,

streptomycin,

sulfonamides, tetracycline; R-type = ACSSuT) (for review of DT104 see [44, 60, 91].
The genes responsible for this phenotype exist as a 14kb genetic cluster that has been
mapped to the organism's chromosome.

Surrounding the cluster are two integrons

containing genes that produce proteins involved in streptomycin, penicillin and
sulfonamide resistance.

Located between the two integrons are genes conferring

resi stance to chloramphenicol and tetracycline [ 10, 11, 12, 86]. The DTl 04 strain was
regularly isolated from dairies prior to its spreading to humans, leading many researchers
to use the organism as an example of how antibiotic resistant pathogens developed on the
farm can infect and cause disease in humans [43, 60, 91].
Indeed, the development of antibiotic resi stant pathogens on the farm and
subsequent infections of humans through the consumption of contaminated foodstuffs is
often cited as the main danger in the agricultural use of antibiotics [64, 68] . There exists
4

other threats, however, that are more difficult to quantify.
many cases, serve as reservoirs for many human pathogen s.

It is agreed that livestock, in

Antibiotic resistance could,

in some cases, afford pathogenic bacteria a means to become better established among
the animal's microflora if the bacterial population is continuously exposed to antibiotics.
In a simil ar manner, it is feared that livestock may also serve as gene reservoirs for the
development of antibiotic resistance in both commensaJ and pathogenic bacteria. Such
bacteria, once established in human bacterial populations, could pass resistance to human
pathogens producing prolonged illnesses or treatment failure [68 , 71]. It follows that in
bacterial populations regularly exposed to different antibiotics, such as the microflora of
a food-producing animal, the prevalence of genes associated with resistance, and
therefore the capacity for a bacterium to develop resistance, could be increased.
The experiments described herein examine one facet of the potential health
hazards associated with the agricultural use of antibiotics, by investigating the
epidemiology of integro ns. As integrons are often implicated in the development of
multiple drug resistance, the intent of these experiments was to ascertain the prevalence
of integrons in three different bacterial populations associated with animal s.

This

measurement would serve as one indication as to: 1) whether such bacterial populations
could serve as reservoirs for both genes and the genetic mechanisms involved the
development of antibiotic resistance; and 2) the capacity of some potential human
pathogens to develop multiple drug resistance.
In the first experiment, integrons, their cassettes and potenti al mobility were
examined in a pool of generic Escherichia coli (E. coli) isolates obtained from swine on
farms with drastically different antibiotic use practices. These results served as a basal
5

measurement of the prevalence of integron DNA in a common gram-negative organism
that makes up part of the commensal enteric flora of the pig. The second experiment
examined integrons in a similar manner, only using a pool of various Salmonella serovars
isolated from several different species of animal.

The results demonstrated the ubiquity

of integron gene capturing systems throughout a genus of bacteria pathogenic to humans.
A final experiment characterized integrons and integron-mediated antibiotic resistance in
Shiga toxin producing E. coli. The results measured the prevalence of integron DNA in a
group of newly emerged foodborne pathogens whose prevalence in animals could be
affected by the selection advantage of antibiotic resistance.
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I. Antibiotics in Livestock Production
The history of the use of antibiotics as feed additives in livestock production dates
back to the late 1940' s discovery that the drugs could afford health benefits to animals
outside of the treatment of disease (for review see [6, 53, 64]).

Interestingly, the

discovery came about somewhat serendipitously through research focusing on the effects
of B vitamins on growth. Several groups of scientists found that when chickens were
administered the vitamin B 12 , in the form of crude Streptomyces aureofaciens
fermentations, the chickens experienced growth at a much higher level than seen when
B 12 was used alone.

It was concluded that the crude fermentations contained an

unidentified growth factor in addition to B 12 [l 13].

Streptomyces aureofaciens is a bacterium that to this day is used extensively in
the fermentation production of antibiotics and in 1950 Stockstad showed that the
unidentified growth factor in the crude fermentations was chlortetracycline [114].
Shortly thereafter, the United States Food and Drug Administration approved the
inclusion of certain antibiotics in livestock rations for growth promot.ion and disease
prevention [64].
Today, close to 8 million kilograms are used in animal production in the United
States alone [24] and it is estimated that approximately 90% of those drugs are used for
disease prophylaxis and/or growth promotion explicitly [63 , 125]. Close to 10.5 million
pounds of antibacterials are used in U. S. pork production each year.

Similarly, it is

estimated that over 10.5 million pounds of antibacterials are used each year in the poultry
industry. Approximately 3.5 million pounds of antibacterials are used each year in the
production of beef and veal.

Estimates of the volume of antibiotics used in dairy
7

production could not be found.

The total volume of antibiotics used in livestock

production is estimated to dwarf that used in human medicine by a ratio of approximately
8 to 1 [8] .

A. Benefits of Antibiotics in Livestock Production: Any debate as to the prudence of
the agricultural use of antibiotics should include a discussion of the economic benefits
that the drugs afford livestock producers. Several researchers have provided estimates as
to the benefits of using antibiotics as feed additives by pooling the data of hundreds of
experiments that examined antibiotics as growth promotants.

The most recent

comprehensive analysis of such benefits is that of Zimmerman and co-workers who
estimated that including antibiotics in swine starter rations translated to a 16% increase in
daily gain and 6.9% improvement in feed:gain .

Similarly, including antibiotics in

growing phase diets was estimated to increase daily gain by 10.6% and improve feed :gain
by 4.5 %. Antibiotics seemingly have the smallest effect on finisher pigs but still are
estimated to improve daily gain by 4.2% (feed:gain improved by 2.2%) [25] .
A similar study by Hays, however, indicates that these percentages may, in fact,
be low as many of the experiments included in the analysis were conducted at
universities. According to Hays, these facilities are generally cleaner and thereby may
have decreased disease loads in comparison to commercial farm settings; a factor that
could limit the efficacy of the drugs .

Indeed, in comparing the growth promoting

capacity of antibiotics when tested in different settings (university farm versus
commercial farm), effects were statistically higher in experiments conducted on
commercial farms [54].
8

Hays ' supposition is supported by the work of Hill and et al.

that showed an inverse relationship between the growth promoting effects of antibiotics
and the sanitation level of the animal's environment [55].
Recently, Cromwell has translated the aforementioned studies into monetary
estimates.

Benefits from improved gain translated to $1.54 (2002 USO) per pig, the

benefits from improved feed:gain translated to $1.75 per pig and the benefits of reduced
post-weaning mortality translated to $0.40 per pig. Estimating the cost of the antibiotic at
$0.70 per pig, Cromwell concludes that including antibiotics in the feed translates to a
$2.99 return on a $0.70 investment [25].

Interestingly, this is three-fold higher than the

losses estimated to have been incurred by Swedish and Danish swine producers following
a total ban of the use of antibiotics for growth promotion or prophylaxis in those
countries [l 10]. Major differences in management systems in U.S. and E uropean farms,
however, could make comparisons between the two difficult.

B.

Antibiotics and Growth Promotion:

While the non-therapeutic benefits of

antibiotics are easily demonstrated [25, 135), the mechanisms by which antibiotics
contribute to growth promotion are less clear and continuall y debated.

Researchers

generall y agree that there are up to four means by which antibiotics achieve their growth
promoting effect (for review see [6, 25, 41, 53, 128].
One proposed mechanism centers around a theory that antibiotics may spare
nutrients such as certain vitamins and amino acids. This would come about presumably
through the antibiotics selectively eliminating certain microbial populations that could
compete with the host animal for the same nu trien ts. A second mechanism involves the
fact that animals fed antibiotics have a decreased intestinal wall thickness comparable to
9

gnotobiotic animals. This could be the result of decreased concentrations of intestinal
irritants produced by bacteria such as ammonia, urea and methane.

Regardless,

decreased thickness of the intestinal wall could facilitate better absorption of nutrients .
The third proposed mechanism centers on the possibility that antibiotics selectively
eliminate pathogenic organisms, thereby preventing subclinical infections and the
metabolic drain such infections could exact on the host immune system. Finally, several
researchers note that as animals fed antibiotics often exhibit increased feed and water
intake and more efficient digestion, there may also be a metabolic effect [6 , 25 , 128].
None of these effects should be considered mutually exclusive. In fact, in three
cases, the proposed mechani sm of growth promotion involves the death of a microbe or
microbial population, with the debate actually focused on what effect the microbial death
may have (eg. nutrient sparing versus subclinical disease prevention).

As such, it is

perhaps the synergy of each mechanism that allows antibiotics to affect the growth of an
animal and not one mechanism in particular. Moreover, many antibiotics are indicated
for disease prevention.

As one proposed mechanism of antibiotic growth promotion

centers around disease prophylaxis, the physiological line dividing antibiotic feed
additives into those that promote growth and those that prevent disease is probably
unclear.
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II. Antibiotic Resistance in Bacteria Associated with Livestock
Stokstad's discovery that low level s of antibiotics can be used effectively as
growth promotants was both immediately preceded and followed by two equally
important, yet more ominous di scoveries involving the use of antibiotics.

Both

discoveries illu strated the adaptability displayed by bacteria, the limits in using
antibiotics to combat bacterial di sease and the potential health hazard m overusing
antibiotics.
The first event occurred just prior to Jukes and Stocktad's discovery and involved
penicillin, the first true antibiotic to be used clinically. Shortly following its introduction
as a systemic therapeutic , clinicians discovered that the targeted bacteria, in some cases,
were able to withstand the lethal effects of the antibiotic [70].

The observation set in

motion the paradigm whereby if a bacterial population is exposed to an antibiotic, certain
members of that population (i.e. those resistant to the drug) will be selected for continued
growth.
The second event occurred almost immediately following the Food and Drug
Admini stration 's approval of the use of some antibiotics as feed additives in livestock
production and involved dysentery outbreaks in East Asia. In Japan , it wa:s observed with
the treatment of Shigellosis, that the Shigella organism not only developed resistance to
the first antibiotic used to treat patients but to a second, third and fourth antibiotic as well
[129].

This event established the idea that a single organism can acquire resistance to

two and, in some cases, several drugs used to eliminate it.
Collectively, the three events have served as a catalyst for a very lively debate
that has continued at length for nearly five decades. It is estimated that human infections
11

with antibacterial resistant pathogens add $1.3 billion (1995 USD) to hospital costs in the
United States alone (125]. The question then becomes - to what extent does the use of
antibiotics for growth promotion and prophylaxis in livestock production contribute to
this health hazard? In the 50 years since these three events, there has been an inordinate
amount of research conducted in an attempt to answer this question . Several surveillance
studies have shown that antibiotic resistance has become well established in many
bacterial populations [see following section].

At the same time the mechanisms of

antibiotic resistance acquisition have been, in many cases, well characterized; as have the
mechanisms of genes and proteins directly responsible for antibiotic resistance (5 , 45 ,
87]. Concurrently, numerous government commissioned inquiries and studies, both in
the United States and abroad, have been conducted in an attempt to answer this question
[6, 64, 118]. Antibacterials, however, are still used extensively as growth promotants and
prophylactics in American livestock production [8, 35, 120) and there is still a great deal
of disagreement as to whether this is a prudent use of the drugs.

What follows is

di scussion of facts surrounding the issue including: 1) selection pressures of antibiotics;
2) surveillance data of antibiotic resistance in several organisms of both agricultural and
human importance; 3) proposed manners of how the agricultural use of antibiotics could
detrimentally affect human health ; and 4) explanations as to why the issue remains
without answers.

There will also be a brief discussion of the experience several

countries of the European Union have had in drastically limiting or banning the use of
feed-based antibiotics in livestock production.
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A. Antibiotic Selection Pressure:

A certain level of antibiotic resistance is always

present in most bacterial populations. It follows that, in the most basic of examples of
antibiotic resistance development, when a bacterial population is exposed to an antibiotic,
those bacteria that are susceptible are eliminated while those that are resistant are selected
for increased growth [80, 99]. As such, resistant bacteria may flourish not by adapting,
but by possessing a drug resistant phenotype prior to the introduction of the antibiotic.
The fact that many bacterial genera possess the ability to both transfer and acquire
genetic material horizontally makes the issue of antibiotic resistance development much
more complex. Indeed, the rapid spread of antibiotic resistance in a bacterial population
after the introduction of an antibiotic is also due to the ability of genes responsible for
antibiotic resistance products to be passed from one species, and sometime genus, to
another [5 , 45, 87, 119].

B. Surveillance Data: Antibiotic resistance would exist in nature without the human
use of antibacterials, due to the fact that most of the compounds are products of
microorganisms and such organisms must have the capacity to withstand the lethal effects
of the drugs for their own survival. The concern, rather, is whether the very powerful
selection pressure put forth by the human use of antibiotics serves to increase the level of
antibiotic resistance in nature. A review of antibiotic resistance survellience data would
indicate that use of antibiotics certainly does facilitate this adaption of bacteria to the
drugs . What follows is a brief survey of studies that have monitored antibiotic resistance
in three bacterial genera (Escherichia coli, Salmonella, Enterococcus) throughout the
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antibiotic era. Where possible, special attention has been paid to the level of resistance in
isolates obtained from agricultural settings.

1. Escherichia coli (E. coli): E. coli is a gram-negative bacterium that makes up part of

the natural flora of both humans and animals [23 ]. It has long been proposed that such
organisms can act as gene reservoirs for the more pathogenic organisms such as

Salmonella or Campylobacter that, for the most part, transientl y infect animals [68, 109].
As such, surveying resistance development in E. coli popul ati ons serves the purpose of
examining the effects of antibiotics on gram-negative commensal organisms and also
measuring the frequency with which more pathogenic organisms may be exposed to
antibiotic resistance mechanisms.
Heightened level s of antibi otic resistance in E. coli isolated from animals treated
with antibiotics are well documented.

Smith first documented the rise in the prevalence

of tetracycline resistant E. coli that coincided with the introduction of the antibiotic into
livestock production. In 1957, only 3.5% of E. coli isolates obtained from di seased
chickens exhibited resistance to tetracyclines. By 1960, the percentage of tetracycline
resistant E. coli isolates had increased to 63 .2%.

Another study conducted by Smith

showed that in 1960 28.6%, 11.4% and 8.6% of E. coli isolates obtained from swine were
resistant to tetracycline, streptomycin and sulfonamides, respectively.

Levels of

resistance to each of the drugs had increased to 38.6%, 40.0% and 22.9% by 1965 (for
review of each study see [ 109]).
Today, E. coli isolated from livestock and agricultural environments are hi ghly
resistant to numerous, diverse antibiotics. An interesting study conducted by Gellin et al.
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examined antibiotic resistance in the University of Kentucky swine herds and found that
36.4%, 74.3 % and 99.6 % of E. coli isolates obtained from a herd regu larly exposed to
antibiotics were resistant to ampicillin , streptomycin and tetracycline, respectively. The
same study exarruned resistance levels in E. coli isolated from a separate herd that had
not been exposed to antibiotics in over 50 weeks. In contrast to the herd that received
antibiotics, only 0.5 % of isolates were resi stant to ampicillin, 12.4% were resistant to
streptomycin and 26.7 % were resistant to tetracycline [42].
Dunlop et al. investigated antibiotic resistance among E. coli isolates obtained
from Canadian swine farms and found that of the isolates obtained from farms that used
antibiotics in both post-weaning and grower-finisher rations, 96.9% were resistant to
tetracycline, 49.6% were resistant to ampicillin , 31.9% were resistant to streptomycin and
59.8% were resistant to sulfisoxazole [29].

Similarly, a study by Mathew eta al. showed

that on hi gh antibiotic use farms, 98.8 % of E. coli obtained from pigs were resistant to
tetracycli ne, 64.6% were resistant to neomycin , 86.0% were resistant to gentamicin , and
29.5 % were resistant to apramycin by the time pigs reached 63 days of age [76].

2. Enterococcus: The enterococci are gram-positive organisms that make up part of the
natural flora of both humans and animals. The genus is made up of eight species but the
two species, faecalis and faecium, predominate.

Although generally considered

commensal organisms, the enterococci are opportunists and will cause disease under
appropriate conditions. Although neither species is considered vi rulent, the number of
human Enterococcus infections has increased dramatically over the past two decades [60,
83].
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Enterococci are intrinsically resistant to a number of antibiotics including most of
the P-l actams. Moreover, the genus ex hibits low level s of intrinsic resistance to many
aminoglycosides and lincosamides. Indeed, penicillin, ampicillin, piperacillin, imipenem
and vancomycin are among the only antibi otics able to inhibit the growth of the
organism. In 1979, researchers first noted Enterococcus isolates exhibiting high levels of
gentamicin resistance and concurrent increases in the number of Enterococcus
nosocomial infection s. By 1990, researchers began reporting Enterococcus isolates that
exhibited high levels of resistance to penicillin.

Shortly thereafter, multiple-drug

resistant Enterococcus, which until then had not been seen, became prevalent [62]. In
recent years, vancomycin resistant enterococci have become increasi ngly burdensome in
hospital settings (62 , 83] .
As neither Enterococcus faecalis nor Enterococcus faecium are considered
virulent, the rise in human Enterococcus nosocomial infections has been directly
attributed to its acqui sition of resistance to dru gs that are routinely used in hospital
settings [83].

Enterococcus is now res ponsible for 110,000 urinary tract infections,

40,000 wound infection s and 25,000 cases of bacteremia each year in the United States
(33, 47 , 62].

3. Salmonella: As one of the most freq uently isolated foodborne pathogens, a large
proportion of antibiotic resistance survei ll ance research has focused on Salmonella.
Shortly following the di scovery of infectious resi stance, Huey and Edwards conducted a
retrospective study examining tetracycline resistance among isolates obtained from
animals prior to 1948. No isolates exhibi ted resistance to the antibiotic. By 1956, 9% of
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isolates developed resistance [58]. In 1962, McWhorter et al. documented that close to
30% of Salmonella isolates obtained from animals exhibited resistance to tetracyclines
[ 109]. A 1981 survey found that the percentage had again increased to 48% [9]. More
recent surveys indicate that upwards to 60% of Salmonella isolates obtained from
livestock are resistant to tetracycline [34, 116] .
A survey of 1251 Salmonella isolates obtained from animals indicated that 935
(75%) of the isolates exhibited resistance to at least one antibiotic [90]. Epling reported
that in 1990, approximately 85% of all Salmonella isolates isolated from pigs were
resistant to one antibiotic or more.

Increased antibiotic resistance in Salmonella has

been attributed to its ubiquity in nature [97]. Several Salmonella serotypes are non-host
specific and, by infecting several different hosts, they may be exposed to many different
antibiotics and many different antibiotic practices (i.e. human medicine versus livestock
production).

Exposure to a multitude of different antibiotics could facilitate the

development of resistance to several diverse groups of antibiotics.

C. Potential Threats to Human Health: If it is agreed that the agricultural use of
antibiotics does, in fact, contribute to the pool of antibiotic resistant bacteria, the question
then becomes whether this contribution is a threat to public health . What follows are
description of the three major proposed manners by which antibiotic resistance that
develops on the farm could negatively affect human health.

1. Potential Health Threat Number One: Livestock are thought to serve as reservoirs
for many human diseases with the foodborne di sease being paramount.

As such, the
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foremost manner by which the agricultural use of antibiotics could negatively affect
human health would be through the consumption of eggs, meat or dairy products
contaminated with antibiotic resistant pathogens.

Infections with such pathogens could

prove more difficult to treat, resulting in prolonged or increased illness (68, 71).
As farms are not closed ecological systems, it is very difficult to quantify whether
an antibiotic resistant phenotype of a pathogen infecting a human did indeed develop
through the use of antibiotics in livestock and did not enter the farm from some other
source . Three cases, however, are often cited as proof that the event does, in fact, occur
in nature. The most well known case is the dissemination of Salmonella enterica var
Typhimurium DT104. The DT104 organism has a core penta-drug resistant phenotype
(ampicillin, chloramphenicol, streptom ycin , sulfonamides and tetracycline).

The

organism was widely isolated from dairy cows before being isolated from humans. Once
the organism gained entrance in the human popul ation , however, it di sseminated very
quickly in both Europe and the United States [44, 60, 91).

The epidemiology of DT104

infections has led many to infer that the DT J04 strain developed directly as a result of the
use of antibiotics on dairies and then was transferred to humans [60, 91 ]. Two factors,
however, confound the issue. First, the DT 104 strain was isolated from exotic birds prior
to its being isolated from dairy cows (82).

Second, the resi stant phenotype does not

exactly match the antibiotics that are used on dairy farms (both on U. S. and European
dairies) [35 , 120]. As such, whether the agricultural use of antibiotics is to blame for
DTl 04 is Jess clear than some research indicates.
A second case frequently cited as proof that antibiotic resistant pathogens
developed on farms can infect humans concerns the use of avoparcm m Europe.
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Avoparcin is an antibacterial licensed only for ve terinary use and, for a time, was used as
a growth promoter in several European countries.

A protein found to confer avoparcin

resi stance, however, confers cross-resistance to vancomycin, one of the "last-resort"
drugs used in the treatment of methicillin resistant Staphylococcus and Enteroccocus
infections in human s.

Upon use of avoparcin in livestock production, the number of

vancomycin resistant enterococci isolated from humans rose substantially while use of
vancomycin in human medicine did not.

Noting this trend , the agricultural use of the

antibiotic was banned in 1996 [1 , 63].
Finally, the most recent event cited as proof of the first potential health hazard of
using antibiotics in livestock production involves fluoroquinolone use in poultry
production. The approval of the use of fluoroquinolones in livestock production was very
controversial and indeed , once the drugs were implemented there was a concurrent
increase in the prevalence of fluoroquinolone resistant Campylobacter isolated from
chickens [ 1, 63].

According to the Food and Drug Administration, this ri se in

flu orquinolone resistant Campylobacter has been mirrored by a similar increase in the
outbreak of fl ouroquinolone resistant camplylobacterosis in humans as a result of
consuming contaminated chicken. The FDA estimated that each year close to 10,000
Americans are infected with fluoroquinolone resistant camplylobacter as the result of
contaminated chicken and are treated with fluoroquinolone therapy [71].

Whether thi s

results in 10,000 treatment failures, however, was not stated. Nevertheless, the Food and
Dru g Administraion has recommended that the use of fluoroquinolones in li ves tock
production be eliminated [ 123].
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2. Potential Health Threat Number Two: The second threat posed to human health b y
the use of antibiotics in livestock is even more difficult to quantify.

By regularly

exposing diverse bacterial populations, such as are present in agricultural settings, to
antibiotics, the prevalence of antibiotic resistant genes within the bacterial population
could be amplified.

Thus the use of antibiotics for growth promotion and prophylaxis

could turn the animal's mjcroflora into a reservoir for resistant genes available to both
commensal and pathogenic organisms [68, 71 ]. It follows that increasing the exposure of
a bacterium to varied and diverse antibiotic resistance genes would facilitate the
formation of antibiotic resistance clusters that are increasingly more prevalent [ 11 , 17 ,
86, 107].

Those organisms could enter the human population as commensals via the

many routes illustrated in Figure 1 and, once established in the human bacterial
population , transfer that resistance to human pathogens.
Hunter et al. documented a case where a strain of bacteria that had developed
resistance to a veterinary antibiotic did , in fact, infect a human. In surveying resistance
levels in both pigs and the surrounding environment, E. coli was from both pigs and a
farm manager that exhibited resistance to apramycin, a drug used to preverit colibacillosis
in poultry and swine [61]. As apramycin is not used in human medicine, their results
implied that common enteric bacteria of livestock could transmjt resistance genes into
human bacterial populations.
A second frequently documented case involved streptogramin use rn Europe.
The antibacterial noursethricin was never used in human medicine. Upon its introduction
as a growth promotant in swine, researchers tracked the level of resistance to the drug in
both medicated pigs and people who li ved and worked in the immediate vicinity. Within
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two years , noursethricin resistant E. coli was isolated from pigs, farm workers, families
of fann workers and their neighbors.

Moreover, the resistance marker was found in 1%

of the urinary tract infection isolates in the area. [59, 68]

3.

Potential Health Threat Number Three:

There exists a third frequently cited

negative effect that the use of antibiotics in livestock production could have on human
health. Many bacterial agents responsible for foodborne diseases in humans use livestock
animals as immediate hosts.

In many cases, the organisms are not pathogenic to the

animal and seemingly exist as part of the natural microflora of the animal (eg. E. coli
0157:H7 in cattle). A common postulate exists stating that if an organism present in the
gastro-intestinal tract is resistant to an antibiotic, introduction of that antibiotic to the
bacterial population could present a selection pressure aiding the colonization of the
resi stant organism. The increase in the E. coli O 157:H7 within the animal could , in turn,
result in an increased risk of contamination of meat, eggs and dairy products either at
slaughter or collection [ 109].
The most frequently cited study supporting this contention is that of Williams et
al.

Using swine infected with a chlortetracycline resistant strain of Salmonella enterica

var Typhimurium, they showed that subsequent treatment of the infected pigs with
chlortetracycline increased both the quantity of Salmonella shed and the duration of
shedding [130].

In the past two decades, however, numerous similar studies have failed to show
that antibiotic resistance necessarily translated to increased pathogen loads [2, 27, 30].
Nevertheless, U. S. pharmaceutical companies are still required by the Food and Drug
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Administration to show that new antibiotics will not increase the pathogen load m
animals before an antibiotic can be approved for use in livestock production [124].

D.

Complicating Factors:

There are three confounding factors that make the

assessment of the risks posed by agricultural use of antibiotics difficult.

The first

difficulty centers around the fact that antibiotic resistance develops from the therapeutic
use of antibiotics as well as the subtherapeutic use [92, 99]. As such, it is extremely
difficult to assess whether resistance is the result of using antibiotics for growth
promotion or prophylaxis, versus the manner in which many believe the drugs were
originally intended , the treatment of specific diseases. Secondly, a large number of the
antibiotics used in livestock production are also used and, perhaps, misused in human
medicine (see Table 2). It follows that there is an inherent difficulty in assigning blame
for the increase in sulfonamide resistance due to how the drugs have been used in
agriculture when sulfonamides have also been used extensively in human medicine for
the prevention of acne [ 127]. Finally, while there exist several antibiotics used solely in
livestock production, the proteins responsible for resistance to several of these drugs
often produce cross-resistance to drugs used either solely or primarily in human
medicine. As an example, the aminoglycoside apramycin is used in the United States
solely for the prevention of colibacillosis in swine and poultry [61 ]. The gene thought to
be responsible for resistance to apramycin, however, produces a modifying enzyme that
confers resistance to gentamicin [106], an antibiotic important in the treatment of
neonatal infections [35] .

As such, it would be very difficult to ascertain whether

someone is infected with what is primarily an apramycin resistant E. coli or a gentamicin
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resistant E. coli. These three factors illustrate the inherent limits in antibiotic resistance
monitorin g in determining the threat the agri cultural use of antibiotics may pose to
human health . It foll ows that they also point out the difficulties in assessing which uses
of antibi otics (both in human and veterinary medicine) should be eliminated if the
development of antibiotic resistance is to be curtailed.

E. The Agricultural Use of Antibiotics in the European Union: Several countries in
the European U nion have initiated restrictions or bans on the use of antibiotics in
li vestock feeds [ 110].

As these countries are often cited by opponents of the use of

antibiotics in U. S. li ves tock produ cti on as having a more progressive agricultural system,
a brief di scussion of the European experience with compari sons to the U. S . experience
is warranted .

1. The Swedish and Danish Experience: The o nl y count ries in the E uropean U nion to
have complete bans on the use of antibioti cs for growth promotion are Sweden and
Denmark [110] . The remainder of the European Union countries are still able to use
fl avomyci n, avilom ycin and salinom ycin as feed additives [ 120]. It may be of interest to
note that ionophores, namely monensin , are used extensively in poultry production
throughout E urope [110] . As those drugs are considered pri maril y anticoccidial in nature
they were not included in the following di scussion .

Regardl ess, with only three

antibi otics approved for use as feed additi ves, the number of antibacterial drugs avail able
to E uropean farmers for use as growth promotants is considerably less than those
avai lable to American farmers.
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Opponents of banning the use of antibiotics for growth promotion and
prophylaxis regularly cite three events as inevitable with the withdrawal of feed based
antibiotics: 1) increased morbidity and mortality; 2) increased reliance on therapeutic
levels of antibiotics; and 3) economic loss due to decreased animal performance (109] .
Both Swedish and Dani sh farmers have been working with a total ban on antibiotic
growth promoters since 2000 and, while data analyzing the effect thi s has had on the
animal industry are relatively new, several reports have indicated that farmers from both
countries have witnessed each of the three potential effects to varying degrees .
The negative effects of withdrawing antibiotic growth promotants have, perhaps,
manifested themselves most visibly in an increased disease incidence associated with
weaning in swine. In Sweden, the removal of antibiotic feed additives has increased total
feed consumption required to reach 25kg by 2-3 kg and increased days to 25kg by 5-6
days. In Denmark, removal of antibiotics in feed has been estimated to decrease daily
gain by l 9g/day throughout the nursery period.

Reductions in both countries have been

associated with post-weaning E. coli or clostridial infections.

In contrast, the ban on

antibiotic growth promotants has not produced a significant effect on growing or
finishing pigs [110] .
As predicted, the increase in clinical di sease associated with removing antibioitics
from feed has resulted in an increase in the administration of drugs for the treatment of
disease.

This increase has not made up for the removal of antibiotics from feed,

however, as the volume of antibiotics now used in animal agriculture in both countries
has been significantly reduced. Nevertheless , the ban on antibiotic growth promotants
has been estimated to cost Swedish and Dani sh swine producers close to $1.00 (2002
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USD) per pig [ 109], roughly one-third of the estimated benefit of the using feed-based
antibiotics in U.S. swine production [25] .

2. The Trouble with Comparison: There are rather large differences between U.S. and
European livestock production systems. Close to 35 % of milk produced in the U. S.
comes from the largest 3% of dairies (>500 head). Similarly, over 50% of pork produced
in the U. S. comes from the largest 2% of swine farms (>5000 sows) [121, 122]. In
contrast, production of pork and dairy products in the European Union is still largely the
result of smaller, family owned operations [98]. As such, in the U. S. there is a greater
concentration of animals/per farm, which could translate into a greater disease load.
Moreover, European countries are governed by stricter animal welfare regulations than
American farmers in terms of stocking density and the provision of bedding. Indeed, the
practice of early weaning (much less medicated early weaning) practiced by swine
producers throughout the U. S. is prohibited in the EU [93].

Taking into account such

differences , the effect of eliminating antibiotics in U. S. Ii vestock production could
actually have a greater impact than that seen in Europe. Therefore, it is difficult, if not
impossible, to extrapolate from the European experience what might result in the U. S. if
this country were to institute a similar ban.
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III. Antibiotic Activities and Mechanisms of Antibiotic Resistance
As many studies examining the issue of antibiotic resistance are doing so on a
molecular or cellular level , a discussion of how antibiotics work and how they are
inactivated is warranted. The types and spectra of antibacterials approved by the Food
and Drug Administration for use in livestock are very diverse and represent several
unrelated families of chemicals [35 , 120]. Included in Table 1 is a li st of antibiotics
approved for veterinary use, the antibiotic families to which they belong and whether the
antibiotics are also used in human medicine. What follows is an explanation of the four
basic antibacterial properties of antibiotics, a li sting of the families of antibiotics used in
livestock production , their modes of action and several mechani sms employed by bacteri a
to withstand the effects of the antibacterial dru gs.

A.

Basic Antibacterial Properties of Antibiotics:

Most antibiotics disrupt the life

cycle of a bacterium in one of four manners: I) interfering with cell wall synthesis; 2)
interfering with peptide initiation and/or elongation; 3) interfering with DNA replication ;
or 4) interfering with the folic acid synthesis pathway [89, 92, 40].

1. Interference with Cell Wall Synthesis: The cell wall of a bacterium consists of
varying layers depending on the genus and species of the organism (Figure 1). While
basic differences in composition exist, generally speaking, the bacterial cell wall consists
of an inner-membrane, surrounded by a layer or layers of peptidoglycan, an outer layer
consisting of species specific lipo-polysaccharides (gram-negative only) and in some
cases a cell capsule [99] .
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A large number of antibiotics exhibit antibacterial activity by disrupting the
integrity of the bacterial cell wall by specific interference with peptidoglycan synthesis.
ln the process of cell wall synthesis, layers of peptidolgycan are cross-linked by the
activity of carboxypeptidase transpeptidase [92]. Thi s process is described schematically
in Figure 2.

The enzyme's substrate is D-alanine which serves to covalently link

different layers of peptidoglycan. Many antibiotics, most notably P-lac tams, are able to
disrupt thi s process by acting as an analog of O-alanine. When incorporated into the
reaction , there is decreased cross-linking, affecting the integrity of the cell wall [92, 40]
(Figure 6).

2. Interference with Peptide Initiation and/or Elongation: Many antibiotics exhibit
antibacterial activity by disrupting either peptide initiation and/or peptide elongati on. ln
bacteri a, the process of translation involves binding of messenger RNA (mRNA) to
ribosomal RNA (rRNA) I protein complexes (ribosomes) and the subsequent recruitment
of complimentary tran sfer RNA (tRNA) /amino acid complexes [69] (Fi gure 3). A large
number of antibiotics, namely the aminoglycosides and tetracyclines, disrupt this process
by binding to ribosomes, thereby preventing either the initiation or elongation of proteins

[40, 89, 92] (Figure 6).

3. Interference with DNA Relaxation and Supercoiling: The bacterial chromosome
exists in the cell as a very large yet compact, supercoiled DNA molecule. The process of
DNA replication and thereby cell replication requires that the DNA molecule be relaxed,
allowing for replication via a polymerase [69]. Thi s pathway is described in Figure 4.
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Many antibiotics, namely the quinolones, are antibacterial in that they irreversibly bind to
enzymes required for thi s process such as DNA gyrase and DNA topoisomerase, thereby
preventing replication of DNA and production of DNA for daughter ceJJs [40, 89, 92]
(Figure 6).

4.

Interference with Folic Acid Synthesis:

Bacterial ceJJs , like mammalian ceJJs,

require a constant repleni shing of tetrahydrofolic acid (THF) for the synthesis of
pyrimidine rings, a basic component of the pyrimidine nucleic acids and certain amino
acids [69]. Thi s pathway is described in Figure 5. Several antibiotics of agricultural
importance exhibit antibac teri al activity by di srupting thi s pathway and are known as
folic acid antagonists.

Folic acid anatagonists are able to di srupt this pathway by

irreversibly binding to either dihydrofolate synthase or dihydrofolate reductase, two
enzymes necessary m the production of THF.

Blocking THF synthesi s prevents

production of nucl eic acid precursors thereby preventing production of DNA [40, 89, 92]
(Figure 6).

The sulfonamides, which are used extensively in both human and veterinary

medicine, are folic acid antagonists.

B.

Antibiotic Families:

Most antibiotic compounds have been grouped into families

based on their chemical structure. Usually, within a family, antibacteri al activity is the
same or very simil ar. Antibacterial spectrum, however, can differ greatly. For example,
ampicillin is effective in inhibiting the growth of Salmonella spp. In contrast, Salmonella
are intrinsicaJJy resi stant to peniciJJin [92]. Included below are descriptions of the major
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antibiotic families, their modes of action and the mechani sms bacteria use to evade them.
Included in Figure 7 are their basic chemical structures.

1.

P-lactams:

The ~-lactams are the oldest group of true antibiotics to be used

systemically. Thi s family of antibiotics includes the penicillin s, the cepholosporins, the
carbapenems and the monobactams . The antibacterial activity of ~-lactams is the result
of the ~-l ac tam ring of each of the drugs which serves as a O-alanine analog in the
disruption of peptidoglycan cross-linking (see Fi gure 2, 6). The spectrum of~ - lactams,
however, is varied. Most penicillin s have a narrow spec trum with activity mainly against
gram-positive organisms. Cephalosporins have a much greater antibacteri al spectrum,
with activity against both gram-positive organi sms and a large number of gram-negative
organisms.

Likewi se, many carbapenems and monobactorams exhibit activity against

both gram-positive and gram-negative organi sms [40, 89, 92]. ~-lactams approved for
use in animal medicine include amoxicillin, ampicillin , cephapirin, ceftiofur, cloxaci llin ,
hetacillin and penicillin [35 , 120]
Bacteri al resistance to ~-lactams 1s usually the result of ~-lactamases which
degrade ~-l actam rin gs, the antibiotics' catalytic center [89, 92] . Resi stance to many of
the

older dru gs

(eg.

penicillin)

is

widespread

[16].

Cephalosporinases

and

carbapenemases have been described , and resistance to the newest generations of ~
lactams has been observed [92, 105] .

2. Tetracyclines:

Tetracyclines represent a large group of broad spectrum antibiotics.

The compounds contain four catalytic rin gs in their basic chemical structure (see Figure
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7).

Tetracyclines are protein synthesis inhibitors and bind preferentially to the 30S

subu nit of bacterial ribosomes thereby blocking the binding of tRNA-amino acid
complexes [43, 57, 89, 92].

Tetracyclines approved for use in veterinary medicine

include chlortetracycline, oxytetracycline and tetracycline [35, 120].
Similar to ~-lactams, resistance to tetracyclines is both widespread and well
documented [9, 29, 58, 74, 109]. Resistance is usually the result of the production of
proteins that serve an efflux function, driving the antibiotic out of the cell cytoplasm [57,
92] . Moreover, although structural] y different, resistance to one tetracycline usually
confers cross-resistance to other compounds of the family [4].

3.

Aminoglycosides:

Like tetracyclines, aminoglycosides are antibacterial mainly

through interfering with peptide initiation and elongation by binding to ribosomal
subunits and preventing the binding of tRNA-amino acid complexes [35, 92].
Aminoglycosides usually consist of a cyclic nucleus with one or two amino cyclitols
attached by a glycosidic linkage [16] (see Figure 7). Aminoglyosides used in veterinary
medicine include apramycin, dihydrostreptomycin , gentamicin, hygromycin , neomycin,
spectinomycin and streptomycin [35, 120].
In contrast to tetracycline resistance, aminoglycoside resistance is usually the
result of modifying enzymes. The majority of these enzymes are acylases or acetylases
which modify the conformation of the antibiotics rendering them unable to recognize
their substrate [16, 43]. Resistance to some aminoglycosides, in particular streptomycin
and spectinomycin, is widespread [31].
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4. Sulfonamides:

Sulfonamides are a synthetic class of antimicrobials and are folic

acid antagonists with a broad antibacterial spectrum.

The active compound in

sulfonamides is sulfanilimide, which is produced upon in vivo cleavage (potentiation) of
the sulfanomide compounds (see Figure 7). In veterinary medicine, sulfonamides are
usu ally used in combination with other antibiotics namely tetracyclines, penicillins and
roxarsone [35 , 120].
Resistance to sulfon amides is widespread in bacteria isolated from both livestock
and humans due, in part, to the spread of class I integrons which contain a sulfonamide
resi stance gene as part of their conserved sequences [7, 72, 115]. Sulfonamide resi stance
involves an efflux mechani sm but sulfonamide resistant THF reductases have also been
described [92] .

5.

Quinolones/Fluoroquinolones:

The quinolones represent a class of synthetic

antibacterials with a narrow antibacterial spectrum ; affecting only gram-positive bacteria.
Florquinolones, a newer, related class of antibacterials, have a much larger spectrum with
activity against many gram-negative organisms.

Both quinolones and florquinolones

prevent bacterial growth by irreversibly binding to DNA gyrase and topoi somerase
preventing relaxation of DNA and, in turn , DNA replication [28 , 92].
quinoJone approved of use in agriculture is enrofloxacin [35].

The only

Carbadox , a related

compound belonging to the quinoxaline family of compounds, is also extensively used in
swine production [35 , 120]
Resistance to quinolones in bacteria associated with livestock is not widespread as
very few of the antibiotics are approved for use in animals. Resistance has been reported,
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however, and in contrast to many antibiotic resistance mechani sms, is thought to be the
result of simple mutations and not acquisition of new genes [28 , 56]. Thi s theory m ay be
changing, however, as new studies have shown the lateral transfer of genes thought to be
involved in quinolone resistance [73) .

6. Other Miscellaneous Antibiotics: Several antibacteri als used in veterinary medicine
belong to smaIJer families or exist as autonomous compounds. These include macrolides,
lincosamides, peptide antibiotics, streptogramins, elfamycins and chloramphenicol.
Macrolides have a moderate spectrum with activity against both gram-positive
and gram-negative organisms. Their activity is similar to aminoglycosides in that they
inhibit protein elongation [92].

Macrolides approved for use in veterinary medicine

include tylosin, erythromycin, oleandomycin and tilmicosin [35, 120].

Resistance to

macrolides is usuaIJy the result of drug modifying enzymes, but mutations have also been
described [92).
Lincosamide antibiotics have a spectrum comparable to macrolides.

Their

activity is also similar in that they disrupt protein synthesis. Lincomycin and pirlimycin
are the two lincosamides approved for use in livestock [89, 92) .
Peptide antibiotics exhibit antibacterial activity primarily against gram-positive
orgamsms.

They are protein synthesis inhibitors and include the polymixins,

vancomycins, and bacitracin. Use of peptide antibiotics in agriculture, and the European
use of avoparcin in pa11icul ar, has been controversial as cross resistance between the
antibiotics and vancomycin , a drug of last resort in the treatment of some gram-positive
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infections, has been reported [1, 63].

The only peptide antibiotic approved for use in

livestock is bacitracin [40, 89, 92].
Chloramphenicol and its derivative florfenicol exist outside of any antibiotic
family. Both compounds are synthetic, have a broad spectrum and are protein synthesis
inhibitors. Both compounds are approved for use in livestock and resistance to both,
through modifying enzymes, has been reported [40, 89, 92].
Finally, virginiamycin, a streptogramin, is used extensively in livestock
production.

Streptogramins are combinations of two unrelated chemicals where the

combination of two compounds is designed to offset resi stance that might arise to one of
the drugs.
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IV. Gene Acquisition and the Evolution of Antibiotic Resistance
Bacteria are geneticaIJy very adaptable to different environments. Nowhere is this
adaptability more studied than in the area of antibiotic resistance development. With the
observation of multiple antibiotic resistant Shigella outbreaks in Japan, it was quickly
realized that what could be produced in vitro was also happening in nature; that is, the
bacterium was not only acquiring resistance clonally but horizontally as well through
acquisition of exogenous DNA [129].

The mechanisms involved in horizontal gene

acquisition have been well studied and it is generally agreed that genes are acquired in
one of three manners: transduction by phage, tranformation by free DNA or acquisition
of plasmid DNA through conjugation [5 , 45 , 87 , 119] (Figure 9).

A.

Transduction:

Resistant phenotypes can be transferred horizontally from one

bacterial cell to another through bacteriophages or viruses that infect bacteria.

In this

process the phage infects the cell and integrates into the bacterial chromosome becoming
a prophage.

The phage is excised from the bacterial cell upon becoming lytic.

The

process of phage excision is not always exact, however, and bacterial genes can become
packaged into the exiting virus particle.

When the phage infects another cell and

integrates into the bacterial chromosome, those bacterial genes can become integrated
into the host genome [87 , 119]. The role of transduction in bacterial genome evolution is
quite large. It is estimated that through evolution up to 17.6% of the E. coli genome is
composed of foreign genes [66, 87]. It is postulated that most gene transfer outside of
antibiotic resistance genes has come about through phage transduction [66].
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B. Transformation: Resistant phenotypes can also be transferred horizontally from cell
to cell through transformation . In this process, free DNA existing outside of the cell is
transferred into the cell. Through a recombination process, DNA is incorporated into the
host genome [79].

While transformation is easily demonstrated in vitro [87], it is

unlikely that many phenotypes, and antibiotic resistance in particular, are acquired in this
manner.

C. Conjugation: While resistance acquisition through transduction and transformation
should not be ignored , it is generally thought that most antibiotic resi stance phenotypes
are horizontally acquired through plasmid conjugation [5 , 68, 87, 11 9].
extra-chromosomal, autonomously replicated fragments of DNA.

Plasmids are

While bacterial

plasmids vary greatly in size, those typically associated with antibiotic resistance are
usually large, ranging from 80 to 200kb.

Moreover, antibiotic resi stance plasmids

usually exist in a low-copy number with only one or two copies of the same plasmid per
cell.

Most importantly, most plasmids associated with antibiotic resistance are

conjugative in that they possess the machinery to tranfer copies of themselves to
adjoining, often times unrelated , bacterial cells [26, 132].
The process of plasmid conjugation is quite elegant.

Through a set of genes

encoded on the plasmid itself, a protein piJus (sex pilus) is formed connecting the donor
cell (male) with the recipient (female) through a conjugal tube. In the replication process
of the plasmid , a copy is passed through the pilus as single-stranded DNA. Once inside
the recipient cell, the plasmid is replicated using the host machinery into functional,
double stranded DNA [26, 132]. This process is described schematically in Figure 10.
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D. Are Resistant Phenotypes Stable? Havin g mostly adaptive genes, the replication of
pl asmids is not always essential to the survival of the cell. Indeed, in the absence of an
antibiotic, the continued ex pression of many plasmid genes would certainl y be at a fitness
cost to the cell. As such, implied in the fact that a large number of antibiotic resistance
genes are part of plasmids and not the bacteri al chromosome, is the notion that antibiotic
resistant phenotypes are not particularly stable [71 , 81 , 107]. Indeed, bacteria can be
easi ly cured of pl asmid s and in many cases antibi otic resistance is seemingly lost as
quickly as it is gai ned if the selection power of the antibiotic is removed from the
bacterial environment.

Thi s notion has led to the postulate that susceptibility to

antibiotics returns upon withdrawal of the dru g [26] .
Recent studies have shown , however, that the return of susceptibi lity is dru g
specific. Studies by Mathew et al. working with the drug apramycin have shown that, in
the case of generic £. coli, there was defi nite increase in the prevalence of apramyci n
resistant organisms upon introduction of the dru g fo llowed by a definite decrease in
resistance when the dru g is removed [75]. The use of apramycin, however, is relatively
new compared to several other drugs. Conversely, in Europe, where the use of many
antibiotics has been drasticall y curtailed or banned, the level of resistance to these drugs
has not abated.

The most notable example is that, following the exclusion of

streptomycin in both human and veterinary medicine and the dramatic restrictions on the
use of sul fo namides, researchers have reported that resistance to both the antibacteri als
has remai ned comparable to levels when the drugs were heavily used [ 19, 32].

The

existence of many an tibiotic resistance genes in clu sters with other antibi otic genes [17]
36

could partially explain this phenomenon where the use of one drug selects for resistance
to unrelated drugs.

Nevertheless, the European experience highlights the need for

molecular based studies that would elucidate if there are significant gene linkages and if
those linkages lead to: 1) the conservation of certain genes at a fitness cost to the cell;
and 2) the continued high levels of resistance throughout the bacterial population .
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V. Integrons

In recent years, many different and diverse genes responsible for antibiotic
resistance have been isolated to integrons. Integrons are genetic elements that aUow a
bacterium to capture foreign antibiotic resistance cassettes. This is accomplished by a
single recombination step termed gene cassette integration.

The fo ]]owing section

examines thi s process in detail. Included are descriptions of the genetic structures of
integrons, the structures and types of gene cassettes, the integron-mediated expression of
integrated gene cassettes and the relation ship between integrons and transposons.
FinaUy, as an interesting aside, the potential evo lu tionary roots of integrons is briefl y
di scussed.

A. The Genetic Structure of Integrons: To date, there are four classes of integrons.
Classification has been based on the homology shared by integrase enzymes and their
correspondi ng DNA sequences.

The di ffere nces between the first three classes in terms

of the reacti ons that they catalyze and the fun ctions that they perform are minimal. It
follows that integron cl asses I, II and Ill can be di scussed together. The fo urth class of
integrons represent a special genetic mechani sms termed the super-i ntegron. The super
integrons are not involved in antibiotic resistance acqui stion but they are often cited as
the evoluti onary ancestor of the antibiotic resistance integrons. As such , several of the
differing properties and fu nctions of super integrons will be di scussed separately.

1. The 5' Conserved Sequences: The structure of each of the four classes of integrons
contains what is ca]]ed the 5' conserved sequence (S'CS). Within this region are three
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features that warrant detailed discussion: 1) DNA sequences encoding for an integrase;
2) DNA sequences that act a recognition sites for the integrase; and 3) DNA sequences
that act as promoters in the expression of inserted gene cassettes. A diagram detailing
each aspect is available in Figure 12.

a. The Integrase: The integrase of each class of integron is responsible for catalyzing
the recombination event by which gene cassettes are inserted into an integron element.
All integron integrases belong to the tyrosine famjly of recombinases of which the
lambda phage integrase is the most studied [ 17, 65]. Integron integrases characterized
thus far are similar in length but share only between 40-60% homology with one another
at the amino acid level [52] (Table 2). Nevertheless, it is postulated that each class of
integron integrase uses the same pool of gene cassettes as substrates, as identical cassettes
can be found inserted in different integron classes [52, 102-105].

b. Integron Attachment Site (attl): In the process of gene cassette incorporation, the
activity of the integron integrase can be likened to that of a topoisomerase . Each integron
integrase recognizes a specific core sequence (GTTRRR YY) located both on the 3' end
of the integron structure and the 3' end of the antibiotic resistance gene cassette. The two
core sequence regions have been named the integron attachment site (att]) and the
cassette attachement site (attC), respectively. The enzyme serves to nick double stranded
DNA in the complimentary DNA sequences of both the integron and gene cassette
creating a recombination cross-over point [50, 51, 65].
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c. Gene Cassette Promoters: Most antibiotic resistance gene cassettes are inserted into
integrons as promoterless, open-reading frames. Downstream of each attl site, however is
a promoter region oriented in the opposite direction of the integrase gene.
sequences act as the promoter for the expression of inserted gene cassettes.

These
The

seq uences have been named the anterior promoter (Pan,) and actually consist of two
promoter systems, promoter one (P 1) and promoter two (P 2) [18, 49, 65, 88].

Four

different versions of P 1 and two different versions of P 2 have been characterized. Their
strengths differ 20 fold with P 1 generally bein g a strong promoter and P2 being weak or
even inactive [36].

Nevertheless, with promoters oriented towards the inserted gene

cassettes, the integron acts as a natural expression vector for antibiotic resistance gene
cassettes [67] .

2. Gene Cassettes: The antibiotic resi stance genes associated with integron-mediated
antibiotic resistance are described as gene cassettes.

DNA sequencing has characterized

nearly 70 gene cassettes associated with integron s. The vast majority encode for proteins
that confer resistance to an antibiotic in some manner (for review see [ I 05]) . Gene
cassettes exist as non-functional DNA fragments outside of the integron in a closed
circular form and are only functional when formally associated with the integron [17,
103].

Their structure is simple, consisting of only an open reading frame and short

sequences of flanking DNA on both the 3' and 5' ends. Two aspects of gene cassettes are
worthy of detailed discu sion: 1) the cassette attachment site; and 2) the open reading
frame. A detailed diagram of both structures is available in Figure 11.
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a. The Cassette Attachment Site: The non-coding sequences downstream of the open
reading frame have been termed both the 59 base pair element (59be) and the cassette
attachment site (attC) (attC will be used here). The attC does not contain coding
sequences, rather it serves as an integrase recognition site in the recombination event (21,
22, 38] .
Remarkably, of the nearly 70 gene cassettes thus far sequenced, no two attC are
identical. The sequences vary in length, ranging from 54bp to 141 bp denoting how 59be
is actually a misnomer [105]. The actual DNA sequences are also quite varied at the base
level but show similarities in overall composition. In all attC there are two consensus
sequences.

A 5 ' consensus sequence has been termed the core sequence (CS) and

consists of the nucleotides GTTRRRY (R

= purine;

Y

= pyrimidine).

The 3' consensus

sequence has been termed the inverted core sequence (JCS) and consists of the
nucleotides RYYY AAC. In all attC, the core sequence and the inverted core sequence
surround groups of inverted repeats of varying length whose function is in the attachment
of the integrase. Moreover, while core sequences vary among the different cassettes, the
sequences are always complimentary within specific gene cassettes [50, 51, 101].
Interestingly, all the attC, while varying considerably in composition, are
recognized by the same integrase (51, 102-106]. Moreover, of the four integrases thus far
studied, it is postulated that each recognize the same attC as a recombination site,
including the integrase of super-integrons [102-106].

b. Open Reading Frame: The open reading frame portion of the gene cassette contains
a coding sequence which, in the vast majority of cases, encodes a protein necessary for
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antibiotic resistance. Most open-readi ng frames found in integron gene cassettes do not
contain a promoter.

As such, expression is dependent upon incorporation into the

integron in the correct orientation to be expressed from the
integrase [17, 49, 65].

Pant

found in the 3' end of the

It shou ld be noted, however, that gene cassettes containing

promoter systems have been isolated, namely the cmlA cassette whose products confer
resistance to chloramphenicol [ 11 2].

c. Types of Cassettes: Nearly 70 integron associated gene cassettes have been isolated.
The vast majority of those characterized produce proteins directly involved in antibiotic
resistance. Two cassettes, however, have been found that confer resistance to quaternary
ammonium compounds used as disinfectants and six open-reading frames have been
isolated whose function is not yet determined (for a comprehensive listing of gene
cassettes see [36, 105]).
Cassettes whose products are involved in antibiotic resistance produce a wide
range of proteins conferring resistance to diverse classes of anti biotics. What follows are
descriptions of gene cassettes grouped by the antibiotic class with which their products
are associated:

i. P-lactam Resistance Gene Cassettes: A large number of gene cassettes encode for P
lactamases, enzymes conferring resistance to P-lactams. To date, 20 disinct P-lactamase
gene cassettes have been characterized [ 105]. In addition to the older P-Iactamases, class
D P-lactamase gene cassettes, whose products confer resistance to P-lactamase inhibitors
(eg. clavulanic acid) are also regularly isolated. Moreover, class B P-Iactamases, which
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include the extended spectrum ~-lactamases, have recently been characterized as gene
cassettes [37].

It should be noted, however, that the majority of ~-lactam resistance

found in Enterobacteriaceae is thought to be the result of bla-TEM ~-lactamases, whose
corresponding genes are not associated with integrons [13].

ii. Aminoglycoside Resistance Gene Cassettes: Twenty-one gene cassettes conferring

resistance to aminoglycosides have been described [104]. The most commonly isolated
aminoglycoside gene cassettes belong to the aad (aminoglycoside adenyltransferase)
family [7 , 72 , 78, 115]. Thi s family of proteins consists of several closely related genes
whose products confer resistance to

streptomycin

and

spectinomycin.

Other

aminoglycoside resistance integron gene cassettes confer resi stance to neomycin,
gentamicin, tobramycin , and kanamycin [37, 106].

iii.

Chloramphenicol Resistance Gene Cassettes:

Twelve gene cassettes whose

products confer resistance to chloramphenicol have been described. The gene's products
confer resistance either through acetylation or an efflux process [ 105]. Genes whose
products are involved in drug modification belong to the cat family of genes. Genes
whose products are involved in chloramphenicol efflux are members of the cml family
and produce inner membrane pumps [37, 105].

iv. Trimethoprim Resistance Gene Cassettes: Thirteen gene cassettes involved in
trimethoprim resistance have been characterized [ 106]. While divided into two groups
based on sequence homology (dfrA and dfrB) , the genes' products are all dihydrofolate
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reductases which confer resistance by affording a dihydrofolate reductase not recognized
by trimethoprim [92].

v.

Other Classes of Antibiotic Resistance Gene Cassettes:

Several other gene

cassettes have been described. Five gene cassettes conferring resistance to quaternary
ammonium compounds have been described outside of the similar gene found in the
3'CS of class I integrons. Two erythromycin resistance gene cassettes, one streptothricin
gene cassette and one rifampin gene cassette have also been isolated [ I 05].

vi. As Yet Unidentified Gene Cassettes: To date, six open reading frames with no
discernable function have been isolated as integrated gene cassettes [48, 102]. These
cassettes are worth mentioning as they may encode for non-antibiotic resistance
functions. As such, they may be the first cases of non-adaptive genes being inserted as
cassettes in an integron structure [ l 02].

3. 3'CS of Class I integrons: Most class I integrons have, in addition to 5'CS, what has
been called a 3'CS in addition to 5'CS. The 3'CS of class I integrons consists of three
open reading frames.

The first open reading frame is the qacELJ 1 gene.

This is a

truncated version of the qacE gene which confers resistance, through an efflux
mechanism, to certain quaternary ammonium compounds used as disinfectants [51, 52].
The qacELJ J of class I integrons should not be confused with the qacE gene cassette
found in some class II integrons. It does not function as an excisable gene cassette [51,
105].
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Immedi ately dow nstream of the qacEL'J l gene is the sull 1 gene whose product
confers resistance to sul fonamides thro ugh an efflu x mechani sm. Downstream of the
sull l gene is an open-reading frame of unknown purpose called ORF5 . Similar 3' CS are
not fo und in other cl asses of integrons [49, 5 1, 65].

B. Integration: Antibiotic Resistance Gene Capture: The recombinati on event by
which integrons capture gene cassettes will be referred to as cassette integration. Most
cassette integration events take pl ace at primary sites, the attachment sites of both the
integron and the gene cassette.

Secondary site cassette integration has been seen in

nature, however, and the impli cati ons of such a recombination event will be di scussed
briefly. The entire process of cassette integration is described schematicall y in Fi gure 13.

1.

Primary Site Integration:

Pri mary site cassette integration 1s a single step

recombination event governed by the integrase. The integrase recognizes core sequences
(GTTTRRRY) shared by both the integron attac hment site and the cassette attachment
site. In the recombination event, the integrase binds to fo ur inverted repeats present in the
attl site and at least two inverted repeats in the attC site. The integrase acts to nick both
consensus sequences between the G and the fi rst T creating complimentary ends and
thereby a cross-over recombin ation point [49, 94] .

The entire reaction is energy

independent and does not require synthesis of new DNA ; two factors that separate the
process from transposition [ 17] .
The integration of one gene cassette does not preclude the integration of others.
Indeed, there seemingly is no limit as to the number of gene cassettes that could be
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incorporated with reports of up to seven antibiotic resistance genes incorporated into one
integron [17 , 77]. Moreover, the process of excision is that of integration only reversed,
and it is postulated that excision is a frequent event leading to the shufflin g of gene
cassettes driven by antibiotic selection and similar integrons with different orders of gene
cassettes [67] .

2. Secondary Site Integration: Integration of gene cassettes into non -i ntegron DNA
has been reported [94] . This results from the presence of a secondary site recognized by
the integrase. The secondary sites characteri zed thus far show simil arity with both the
attC and attl and usuall y have a consensus sequence of GWTMW (W = T/A; M = A/C)
[25].

The best example of secondary site cassette integration is the integration of the

aadB gene into the broad host range IncQ plasmid RSF1010 [94].
The process of secondary site cassette integration , however, 1s rare and the
reaction is generall y considered inefficient.

It is worthy of menti oning, however, as: I )

it has been reported to occur in nature ; and 2) it has been hypothesized as a manner in
which new gene cassettes could be developed [102].

3. Other Recombination Events: The movement of gene cassettes can also come about
by recombination events involving integrated gene cassettes in different integrons. In
thi s process, two integrons in two different locations of the genome would form a co
integrate. The recombin ation event would lead to integrons trading gene cassettes or one
integron gaining a cassette from the other integron. Research has shown recombination
events involving both attl-attl and attC-attC [46].
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C. Integron Relationship with Transposons: In the strictest terms, integrons are not
mobile. The conunon integron structure lacks the mechanisms needed for transposition.
A large number of integrons, however, have been found on transposons.

The most

notable example is Tn21. Tn2l is a member of the Tn3 family which is probably the
most widely di stributed transposon in both gram-positive and gram-negative bacteria.

Tn2l is a mercury resistant transposon (i.e. contains the mer operon) that contains the In2
integron.

It follows that the In2 integron, conferring streptomycin/spectinomycin , is

arguably the most widely distributed integron.

Tn21 is often found associated with

broad-host range plasmids which serve to further the elements di stribution [ 17, 37, 72].
Integrons themselves are usually defective for transposition.

They often contain,

however, elements that would indicate possible mobility such as truncated resolvases and
insertion sequences . Indeed, Brown et al. argue that most integrons are actually defective
transposon deri vatives. Insertion into certain transposons, however has allowed for their
dissemination throughout several bacterial populations [ 15].

Confusing matters,

however, is the case of Tn402 . Having only genes necessary for either transposition of
integration, Tn402 is considered both a transposon and an integron [52] .

D. Super Integron and Origins of Integrons: One of the more interesting aspects of
integrons is the speculation surrounding their origins. The most well known theories
belong to Rowe-Magnus and Maze} who hypothesize that the first three classes of
integrons have probably evolved from the fourth class, the super-integrons. The super
integrons have been found in only a few bacterial genera with the most extensively
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studied super-integron belonging to Vibrio cholerae.

On the smaller of the two Vibrio

chromosomes lies the prototypical super-integron .

It is over 126kb in length and

contains at least 179 gene cassettes. The super-integrons are differentiated from the other
three classes of integrons based, not only on size, but the facts that: 1) super-integrons are
not thought to contain antibiotic resistance genes; 2) the gene cassettes fo und in super
integrons, in contrast to most antibiotic resistance genes, contain promoters; and 3) the
cassette attachment sites of the nearly 180 gene cassettes are hi ghly conserved [101 , 102,
104].
There are several characteristics of super-i ntegrons, however, that indicate that
they are at least related to antibiotic resistance integrons. Foremost is the fact that 13
antibiotic resistance gene cassettes have been identified with cassette attachment sites
virtually identical in length and sequence to the hi ghl y conserved cassette attachment site
of super-integron cassettes.

Secondl y, the integrases of both antibiotic resistance

integrons and super-integrons catal yze the same reactions. That is, anti biotic resistance
cassettes can act as subs_trates for the super-integron integrase and super-integron
cassettes can act as the substrate for antibi otic resistance integron integrases [ J02].
Through phylogenetic mapping, Rowe-Magnus et al. postulate that the super
integron is an ancient structure, possibl y predating the antibiotic era by thousands of
years.

Their hypothesis is that antibi otic resistance integrons developed from super

integrons through the entrapment of integrases and attachment sites by mobile elements
such as transposons and subsequentl y di sseminated into other popul ations [102].
Unanswered, however, is the development of cassettes and the fact that the vast
majority of antibiotic resistance gene cassettes are promoterless whereas the cassettes of
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super-integrons contain promoters. The fact that most antibiotic resistance gene cassettes
do not contain promoters hints that they may have evolved through reverse transcription.
This could have resulted from a retrovirus or even a bacterial enzyme as bacterial reverse
transcriptases have been identified [95].

Nevertheless, it would appear that integrons

have continued to evolve throughout the antibiotic era as cassettes conferring resistance
to the newest antibiotics are now being characterized [37].
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VI. An Agricultural Perspective of Integrons
A large number of studies examining integron-mediated antibiotic resistance have
been conducted by agricultural scientists.

The major impetu s for this research has been

the rapid dissemination of Salmonella enlerica serovar Typhimurium DT 104. The rapid
proliferation of the DT104 is arguably due in large part to some (as yet unidentified)
virulence factor or factors coupled with the fact that DT104 isolates regularly exhibit a
core penta-drug

resistant

phenotype

sulfonamides, tetracycline; R-type

(ampicillin,

chloramphenicol,

streptomycin ,

= ACSSuT) [44 , 60, 91].

Threlfall originally postulated that the genetic mechani sms responsible for
resistance in DT104 were chromosomally located and not pl asmid borne [117].

Such a

supposition originally ran contrary to the paradigm where antibiotic resistance, and
multiple-antibiotic resistance in particul ar, was largely the work of conjugative plasmids
and transposons. Subsequent sequencing studies, however, did reveal the presence of a
I 3kb clu ster of antibiotic resistance genes as part of the DT l 04 chromosome. The cluster

consisted of two class I integron s containing gene cassettes conferring resistance to
streptomycin and ampicillin.

Between the two integrons were genes encoding

chloramphenicol/florfenicol resistance proteins and tetracyline resistance regulators and
proteins [ 10, 11, 86].

A. Salmonella Genomic Island I: It is now recognized that the antibiotic resistance
gene cluster is only part of a larger gene cluster termed the Salmonella Genomic Island I
(SGil).

Boyd et al. have worked extensively to sequence the island.

The entire

sequence is 42,415 bp in length and consists of 44 open-reading frames. The G + C
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content, an indicator of the origin of genes, varies greatly throughout the island and
segments can be found as high as 60% and as low as 40%. In DT104, the island sits
between the thdF gene and a cryptic retron (retrophage) [ 10, 11]. Figure 14 is a diagram
of the SGil.

1. Multiple Drug Resistance Cluster:

The genes responsible for the core DT104 R

type are located in a 13kb cluster found on the right section of the island. The antibiotic
resistance cluster consists of two class I sull1-type integrons. The two integrons contain
the genes aadAJ and psel conferring resistance to streptomycin and ampicillin,
respectively. Located between the two integrons are the genes, floR, tetA and tetG. The
_fioR gene produces a protein that confers cross resistance to chloramphenicol and

florfenicol

and

was, until

recently, believed to be indigenous to Salmonella

Typhimurium. The tetA and tetG genes make up a two protein tetracyline resistance
system. The tetG protein affords tetracyline resistance through an efflux pump. The tetA
protein is the regulator of tetG transcription.

Interestingly, three genes whose products

are involved in gene mobility, (tnpR, orf2, and /S6100) are also found on the antibiotic
resistance cluster.

The tnpR gene, located upstream from the first integron, produces a

resolvase. The orf2 gene is located upstream from the second integron and produces a
transposase-like gene. Finally, 1S6100, the only insertion sequence in SGil is located
between the second integron and the right junction [ 10, 11 ].

2. Other Genes of Interest in SGll: Boyd et al. characterized several other genes of
the SGil and interestingly, many of them produce proteins involved in either gene
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acquisition or transfer.

Several open reading frames showed significant sequence

similarity to plasmid genes involved in mating pair formation and DNA transfer. One
open reading frame encodes a putative helicase whi le another is a DNA replication
protein gene.

Moreover, integrases outside of the integron integrases have been

identified, as has an excisionase [ 10, 11].

B.

Surveys of Integron Prevalence:

The elucidation that the penta-drug resistant

phenotype in DT104 is, in part, integron-mediated has led to several groups surveying the
presence of integrons in different bacterial populations. In an examination of multidrug
resi stant E. coli isolated from swine, Sunde and Sorem reported that of 134 multi
resistant isolates , 17 were found to carry class I integron gene sequences. In each case
the integrons contained streptomycin resistance cassettes. In eight cases, the integrons
were plasmidic and the resistant phenotypes could be transferred to suscepti ble strains by
conjugation [115).

Martinez-Freijo et al., however, found a much higher percentage of

integron-positive clinically important gram-negative isolates. In surveying 163 isolates
from 14 different European hospitals, 43 % of the samples contained class I integron gene
sequences. Although quinolone resistance is not known to be integron-mediated, their
study showed that integron containing isolates were more likely to be resistant to the
drugs [72). Concurrently, Bass et al. found a higher percentage of integron-positive E.

coli in isolates from diseased birds (63%). All isolates contained an aadA gene as an
inserted cassettes. Fifty percent of the aadA containing integrons were found on the
transposon Tn21 [7].
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Two groups have looked at the prevalence of integrons in aquatic environments.
Schmidt and et al. found class I integron gene sequences in 27 of 313 Aeromonad isolates
obtained from trout farms. In 15 conjugation experiments, tetracycline resistance was
transferred to the susceptible host, along with the integron , indicating a linkage of some
man ner between the two geneti c mechani sms [ 108] (tetracycline resistance is not
integron mediated [37]).

Rosser and Young, however, provided a much more

comprehensive stud y rn examrnrng over 3000 gram-negative isolates taken from an
aquatic environment.

Among their samples, only 3.6% were found to carry cl ass I

integrons [ 100] . As such , a comparison of results suggests that class I integrons, like
virulence factors, are perhaps more prevalent in clinicall y important isolates.
Finally, two studies have investigated the prevalence of integrons in Salmonella
outside of the DT104 strain. Brown et al. surveyed Salmonella enterica var Enteriditis
isolates for integron gene seq uences and found that 11 of 57 sulfamethoxazole-resistant
isolates contained cl ass I integron s. While inserted cassettes were not identified, each of
the 11 integron containing isolates was phenotypically resistant to streptomycin [14] .
FinaIJy, a stud y b y Natasi and Mammin a examined integrons in low-prevalence

Salmonella serotypes.

Integrons were found in 15 different serovars and, in contrast to

most other studies, a wide variety of in serted cassettes were identified [85] .
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VI. Objectives of the Current Studies
There are three major potential health hazards assoiciated with u ing antibiotics
for growth promotion and prophylaxis in livestock. First, there is the fear that antibiotics
will facilitate the development of antibiotic resistant pathogens that could infect humans
through the consumption of contaminated meat, eggs or dairy products. Second, there is
the fear that common commensal bacteria could become resistant to antibiotics, establish
themselves in the human bacterial population and transfer that resistance to human
pathogens [71] . Finally, there is the fear that antibiotic resistance in foodborne pathogens
that commonly use the animal as an immedi ate could present the organism with a
selection advantage resulting in the increased risk of contamination of food products. All
three fears are not unfounded but very difficult to quantify. The objectives of the current
experiments were to assess one facet of the health risks involved in the use of antibiotic
in agriculture by examining integrons and integron mediated antibiotic resistance in
different bacteria associated with animals.
Three experiments were conducted and each experiment was designed as a survey
of a different type of bacterial population.

Figure 15 is a schematic describing the

survey. In each case, different pools of bacterial samples were screened for the presence
of integron gene sequences. Those isolates found to contain integrons were further
characterized by: 1) assessing susceptibility to a battery of commonly used antibiotics; 2)
assessing the number and types of antibiotic resistance gene cassettes present in the
different integrons; 3) evaluating the genetic relatedness of the different integron positive
isolates ; and 4)

determining whether the integron and the associated resistance

phenotype could be passed horizontally to susceptible strains of bacteria.
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The first experiment examined integrons in a pool of E. coli isolates obtained
from swine. The isolates were unique in that they were obtained both from pigs on farms
where antibiotics were extensively used and pigs on farms where antibiotics were
excluded. The results of the first experiment assessed the basal frequency with which
generic E. coli, gram-negative organisms that make up part of the common intestinal
flora of the pig, contain mechanisms by which mu ltiple drug resistance can develop. The
second experiment examined integrons in a pool of Salmonella isolates.

The isolates

represented various serovars and were obtained from a variety of animal species. The
results of thi s ex periment demonstrated the ubiquity of the integron gene capturing
system throughout a bacterial genus whose members are all pathogenic to man. The third
experiment examined the prevalence of integrons in Shiga toxin producing E. coli
(STEC). Similar to the second experiment, the results of this experiment measured the
antibiotic resistance development capacity of a human pathogen but also a recently
emerged infectious disease and an organism whose prevalence in the animal's bacterial
population could be affected by the selection advantage of antibiotic resistance.
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TABLE 1. Antibacterials approved for use in cattle, poultry and swine. (compiled from

[25,35,89,92, 120].
Used in:
Drug

Antibiotic Family

Feed?

Amoxicillin
Ampicillin
Apramycin
Arsanilic acid
Bacitracin
Bambermycin
Carbadox
Ceftiofur
Cephapirin
Chloramphenicol
Chlortetracycline
Cloxacillin
Dihydrostreptom yci n
Efrotomycin
Erythromycin
Enrofloxacin
Florfenicol
Gentamicin
Hetacillin
Hygromycin
Lincomycin
Neomycin
Novobiocin
Oleandomycin
Ox ytetracycline
Penicillin
Pirlimycin
Roxarsone
Spectinomycin
Streptomycin
Sulfabromomethazine
Sulfachloropyridizine

P-lactam
P-lactam
aminogl ycoside
arsenic al
bacitracin
bambermycin
quinoxaline
cephalospori n
cephalosporin
chloramphenicol
tetracycline
P-lactam
aminoglycoside
elfamycin
macrolide
quinolone
chloramphenicol
aminogl ycoside
P-lactam
aminoglycoside
lincosamide
aminogl ycoside
dibasic acid
macrolide
tetracycline
P-lactam
lincosamide
arsenical
aminogl ycoside
aminogl ycoside
sulfonamide
sulfonamide

no
no
yes
yes
yes
yes
yes
no
no
no
yes
no
no
yes
yes
no
no
no
no
yes
yes
yes
yes
yes
yes
yes
no
yes
no
no
no
no

Human Medicine?
yes
yes
no
110

yes
no
no
no
yes
yes
yes
yes
yes
no
yes
no
yes
yes
yes
no
yes
yes
yes
yes
yes
yes
no
no
yes
yes
no
no
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TABLE 1 (continued). Antibacterials approved as feed additives for cattle, poultry and
swine.
Used in:
Drug

Antibiotic Family

Feed?

Human Medicine

Sulfadimethoxine
S ulfaethox ypyridazine
Sulfamerazine
Sulfamethazine
Sulfamethoxine
Sulfanitran
Sulfaquinoxaline
Sulfathiazole
Tetracycline
Tiamulin
Tilmicosin
Tylosin
Virginiamycin

sulfonamide
sulfonamide
sulfonamide
sulfonamide
sulfonamide
sulfonamide
sulfonamide
sulfonamide
tetracycline
diterpene
macrolide
macrolide
streptogrammin

yes
yes
yes
yes
yes
yes
yes
yes
no
yes
yes
yes
yes

no
no
no
no
no
no
no
no
yes
no
no
no
no
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TABLE 2. Integron integrase homology. (adapted from [52].
% Amino Acid Sequence Homology

Integrase

Intll

IntI2

IntI3

lntl4

Intl

100

46.5

59.6

45.5

Intl2

63.0

100

46.3

49.2

lntI3

72.8

59.7

100

44.8

Intl4

64.3

64.3

62. 1

100
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Figure 1. Cell wall composition in (A) gram-negative and (B) gram-positive bacteria.
Adapted from [99]
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Figure 2. Peptidoglycan cross-linking in the synthesis of bacterial cell walls.
Several antibioti cs, most notabl y the ~-lactams, are antibacteri al in acting as D-alanine
analogs. The incorporation of the antibiotic in place of D-alanine prevents cross-·
linking of peptidolgycan, thereby destroying the integrity of the cell wall. Adapted
fro m [92].
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Figure 3. Protein initiation and elongation in bacterial cells. Peptide
elongation takes place on ribosomal RNA/protein matrices where tRNA-amino
acid complexes complimentary to mRNA codons are recruited.
Several
antibiotics block this pathway by binding to the ribosome and preventing peptide
intiation or elongation. Adapted from [69, 99)
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Figure 4. Relaxation and supercoiling of DNA. Several antibiotics, namely the
quinol ones inhibit DNA relaxation and supercoi ling by binding to either DNA gyrase or
topoi somerase. The result is an inhibition of DNA replication . Adapted from [ 126].
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(99].
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Figure 9. Three major mechanismss by which antibiotic resistance phenotypes are
transferred horizontally among bacteria. A) Tran sduction : bacteriophage containing
bacterial genes transduce bacteria through phage lytic cycle; B) Transformation: free DNA
is taken up by bacterial cell and incorportated into genome through recombi nation; C)
Conjugation: plasmid DNA containing antibiotic resistance gene is passed from donor to
recipient through pilus.
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Figure 10. Schematic describing the transfer of an antibiotic resistant phenotype
through the process of conjugation. A. Through plasmidic genes, a protein pilus is
formed joining the two cells. B. Plasmid DNA is transferred to the recipient cell as single
Single stranded plasmid is replicated using the host machinery into
stranded DNA. C.
double stranded, functional DNA . Adapted from [26, 132]
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PART TWO: CHARACTERIZATION OF CLASS I INTEGRON IN E.COLI
ISOLATED FROM SWINE UNDER DIFFERENT ANTIBIOTIC
MANAGEMENT PRACTICES
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Abstract

The use of antibiotics in agriculture remains controversial due to the development of
antibiotic resistant bacteria. Most bacteria of agricultural importance develop antibiotic
resistance through the acquisition of foreign DNA. Recent research has shown that, in
many cases, the acquisition of multiple resistance genes arises through integrons, genetic
elements that direct the site-specific recombination of foreign antibiotic resistance genes.
In an experiment examining class I integrons in Escherichia coli obtained from healthy
swine, 10.5% of 153 isolates were found to contain integrons. Preliminary analysis
indicated that a higher percentage of integron containing E. coli was isolated from pigs
on farms where antibiotics were used ( 14. l % ) (regardless of the types of antibiotics used)
versus pigs on farms where antibiotics were excluded (5.8%).

Antibiotic resistant

phenotypes could not be transferred to a susceptible strain via electroporation.
Conversely, one isolate was able to transfer both a streptomycin resistance phenotype and
an integron genotype to a susceptible strain.

Macrorestriction profiling of the integron

containing isolates revealed several unrelated biotypes. Sequencing and PCR mapping,
however, showed that in each case the integrated cassettes showed similarity to a gene
conferring resistance to streptomycin/spectinomycin (aadA).

These data suggest that

integrons are common among the natural enteric flora of swine. Such strains may act as
reservoirs for both antibiotic resistance genes and mechanisms by which multiple
antibiotic resistance develops. Additional research is needed to ascertain whether the use
of antibiotics on swine farms, regardless of the type of antibiotic, selects for such isolates
as these data suggest.
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I. Introduction

The use of antibiotics in U. S. animal production provides the industry the ability
to produce affordable meat, eggs and dairy products [6].

The increase in antibiotic

resistant bacteria associated with such uses of the drugs, however, is both well
documented and problematic [9, 17, 18]. In recent years, many of the genes responsible
for bacterial antibiotic resistance have been mapped to specific sites known as integrons;
DNA structures that allow the site-specific recombination and expression of exogenous
genes [15].
lntegrons have been found on plasmids, transposons and as independent units on
the bacterial chromosome [3, 15] and, by definition, contain three elements that all ow the
incorporation of foreign antibiotic resistance genes:

1) a recombination or attachment

site; 2) an integrase which recognizes specific sequences on the extra-integron gene
cassette and the recombination site; and 3) a strong promoter that allows the integron to
act as an expression vector [5 , 12, 14, 25] .
Classification of integrons is based on integrase homology and, thus far, four
classes have been described [15]. The integrons most frequently isolated from members
of the Enterobacteriaceae family, however, belong to class I and aside from a
homologous integrase, class I integrons usually contain at least two other conserved
features: 1) resistance to certain disinfectants and dyes (qacE11); and 2) resistance to the
sulfonamides (sul/1) [1, 8, 23] .
The development of multiple antibiotic resistant bacteria is often attributed, in
part, to a strain's integration of foreign gene cassettes.

Indeed, the development of

multidrug resistant Salmonella enterica serovar Typhimurium DT104 is due, in part, to
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the chromosomal incorporation of two class I integrons [22]. It follows that the enteric
bacteria of livestock may act as reservoirs of antibiotic resistance genes for foodborne
pathogens that transiently infect food animals (eg. Salmonella, Campylobacter,
Enterotoxigenic E. coli, etc.). As such, it was of interest to determine the frequency with
which common enteric bacteria in healthy swine carry class I integrons.

The first

objective of the present study was to screen a large pool of Escherichia coli isolated from
swine for the presence of class I integron DNA sequences. The second objective was to
characterize such isolates in terms of integron location, genetic relatedness and types of
integrated cassettes.
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II. Materials and Methods
A. Bacterial Isolates:

One hundred fifty-three swi ne derived E. coli isolates were

chosen at random from a pool of isolates obtained from four swine farms that regularly
used antibiotics (ab+; n=85) and three swine farms that excluded antibiotics (ab-, n=68).
The primary isolation method has been described previously

(19] .

The antibiotic

histories of each ab+ farm are listed in Table I. The pool of test isolates represented E.
coli obtained from pigs at different growth stages ( lOlbs, 501bs, 10O!bs, 240lbs) and

breeder sows.

B. Multiplex PCR (MP-PCR): lntegron harboring isolates were detected using a MP
PCR targeting three conserved sequences of class I integrons (qacEiJJ , intJJ and sulJJ ).
Primer pairs were designed using published sequences (GenBank accession no .
AF161825) and manufactured by Operon, Inc. (Alameda, CA) (Table 2) . Total DNA
was prepared by boiling overnight cultures in 2YT broth in an equal volume of 0.2%
(wt/vol) Triton X- 100 (Mallinckrodt, Paris, KY) for five minutes (16]. Boiled cultures
were cooled on ice for 5 min and used immediately for PCR. PCR reagents, excluding
template DNA, were combined in a master mix prior to aliquoti ng. The final reaction
volumes for each aliquot included: 1) 1 µL of each primer pair (50pmol [each primer]
µL-\ 2) 1 µL of Taq DNA polymerase (0.5U µL _,; Promega, Madison, WI); 3) 10 µL
reaction buffer (12.5mM MgCh, pH 8.5; Invi trogen, Carlsbad, CA); 4) 5 µL dNTPs
solution (2.5mM of each dNTP, pH 8.0; Invitrogen) ; and 5) 32 µL sterile H 20. Sample
DNA (1 µL) was then added to each aliquot. Reactions were conducted in a Mastercyler
Gradient thermocycler (Eppendorf, Westbury, NJ) with the following conditions: 1) 1
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cycle of 94 °C for 4 mjn; 2) 10 "touchdown" cycles of 94 °C for 1 min, 65 °C for 30s
(decreasing 1°C/cycle), 70°C for 2 min; 3) 24 cycles of 94°C for 1 min , 55°C for 30s,
70°C for 2 min; and 4) I final cycle of 70°C for 5 min. Salmonella Typhimurium DT104
(provided by Dr. Timothy Barrett of the Centers for Disease Control and Prevention),
known to contain two class I integrons [23], was used as a positive control. A blank
containing only PCR reagents and Triton X-100 was used as a negative control.
Reaction products were separated by conventional electrophoresis in 1.5 % agarose and
stai ned with ethidium bromide for visualization.

C. Antibiotic Susceptibility Testing: Integron containing isolates were screened for
resistance to 16 antibacterials or antibacterial combinations (amoxicillin/clavulanic acid,
ampicillin, apramycin , cefoxitin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol,
ciproflaxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole,
tetracycline, trimethoprim/sulfamethoxazole) using the broth dilution method according
the guidelines published by the National Antimicrobial Resistance Monitoring System
[22].

D. Integron PCR and Cassette Sequencing: Integrated gene cassettes were amplified
by PCR using primers specific for the 5' and 3' conserved ends of class I integrons.
Primers were designed using published sequences (GenBank accession no. AF161825)
(Table 2). PCR reagents, excluding template DNA, were combined in a master mix prior
to aliquoting. The final reaction volumes for each aliquot included: 1) 1 µL of a primer
pair solution (50 pmol [each primer] µL -1) ; 2) 1 µL of eLONGase (l.OU µL - 1; Life
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Technologies, Inc., Gaithersburg, MD); 3) 10 µL reaction buffer (12.5rnM MgCh, pH
8.5); 4) 5 µL dNTPs solution (2.5rnM of each dNTP, pH 8.0); and 5) 32 µL sterile H 20.
Sample DNA (1 µL) was then added to each aliquot. Reactions were conducted in a
Mastercyler Gradient thermocycler with the following conditions: 1) 1 cycle of 94°C for
4 min; 2) 10 "touchdown" cycles of 94°C for 1 min, 65°C for 30s

(decreasing

1°C/cycle), 70°C for 4 min; 3) 40 cycles of 94°C for 1 min, 55°C for 30s , 72°C for 4

min ; and 4) 1 final cycle of 72°C for 5 min. Salmonella Typhimurium DT104 was used
as a positive control.

Antibiotic susceptible Salmonella Typhimurium (#7393) was used

as a negative control. Reaction products were separated as previously described. PCR
products were directly purified using the Wizard PCR Prep kit (Promega) according to
the manufacturer's instructions. Direct sequencing of PCR products was provided by The
University of Tennessee Automated DNA Sequencing Facility (Knoxville, TN).
Comparisons were made to published sequences (GenBank accession no. AF161825).
The identities of those cassettes that were not directly sequenced were confirmed by PCR
targeting a gene sequence bridging intll to aadA. Design of primers and reaction were as
described previously (Table 2).

E.

Transformation and Conjugation:

The location of integrons (plasmid versus

5
bacterial chromosome) in each samples was determined by transformation of str E. coli

InvaF' (lnvitrogen).

Samples were grown overnight in Luria Bertani (LB) broth

containing 64µg/mL streptomycin.

Plasmid DNA was prepared using the lysis in

solution method as previously described [7].

Plasmid DNA was (2 µL) combined in

solution with 40 µL electrocompetent InvaF'.

Cells were transformed using an
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Electroporator II (lnvitrogen). Transformed ceJJs were resuscitated in SOC medium for
1.25 h and plated on LB agar containing 64µg/mL streptomycin.

A Salmonella

Typhimurium, harboring a 70kb Strr plasmid was used as a control.

In conjugation experiments, both donor and recipient (st/. nalR Salmonella
enterica Typhimurium #4232) were grown separately to reach an O.D.600 = 0.5. One
milliliter of each donor and recipient was combined in four mL LB and liquid mated
overnight.

Transconjugants were selected by incubating MueJJer Hinton agar plates

containing S0µg/mL nalidixic acid and 32µg/mL streptomycin with IO0µL of mated
culture.

Transconjugants were grown overnight in LB and PCR targeting sequences

bridging inti1 to aadA was performed using reaction parameters already described.
Plasmid DNA was isolated from presumptive transconjugants by the lysis in solution
method and separated by electrophoresis.

F.

Macro-restriction Profiling (MRP):

MRPs were generated by pulsed-field gel

electrophoresis (PFGE) utilizing the rapid method described by Gautam [13].

One

miJJimeter slices from each sample plug were digested in Xbal (Roche Diagnostics,
Indianapolis, IN).

Digested plugs and reference strains (E. coli O157:H7 ; kindly

provided by Barbara GiJJespie, The University of Tennessee, KnoxviJJe, TN) were
separated by PFGE and stained with ethidium bromide for visualization as previously
described.

AJJ gels were photographed over a UV transiJJuminator and digitized by

computer. MRPs were visuaJJy analyzed and compared using the guidelines of Tenover
[24]. Relatedness of MRPs was also computer analyzed (Molecular Analysis Software,
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BioRad) by generating Unweighted Pair Group Method with Arithmetic Averages
(UPGMA) clu sters based on Dice coefficients of each band pattern [21 ).
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Ill. Results
A.

PCR Detection of Class I Integrons:

MP-PCR was successful in consistently

identifying class I integron conserved sequences in the control strain Salmonella
Typhimurium DT104 #G9086 (Fig. 1). When the pool of isolates (n=153) was screened
for integron sequences using this reaction, a total of 16 (10.5 %) class I integron
containing isolates were detected. Of the 16 class I integrons detected, 12 ( 14.1 % of total
ab+ isolates tested) came from isolates obtained from pigs fed antibiotics while 4 (5.8%
of total ab- isolates tested) were from pigs not exposed to antibiotics .

Two class I

integrons detected in isolates from pigs fed antibiotics were incomplete in containing
both qacELJJ and sulll but missing intll.

These were included as integron-positive

isolates based upon further examination and discussed in the inserted cassettes section.
Two integrons detected in isolates from pigs fed antibiotics were class I non-sullI-type
integrons. The remainder of integrons detected were class I sullI-type integrons (Table
3).

B. Antibiograms of Integron Positive Isolates: Of the 16 putative integron containing
isolates, all were resistant to the tetracycline family of antibiotics. All but three integron
positive isolates were phenotypically resistant to sulfamethoxazole.

One isolate was

resistant to five antimicrobials while four were resistant to four antimicrobials. Several
were resistant to various antibiotics including gentamicin, streptomycin, apramycin,
ampicillin, cephalothin, trimethoprirn/sulfamethoxazole and kanamycin (Table 3).
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C. MRPs of Integron Positive Isolates: When analyzed visually, two isolates (3-2 and
3-3) from one ab+ farm were deemed clones having indistinguishable MRPs. A third
isolate (3-4) produced an MRP that differed from 3-2 and 3-3 at only two locations,
deeming the three very closely related. Likewise, two integron positive samples (6-2 and
6-3) isolated from a single ab- farm were deemed clones, having indistinguishable MRPs
(Figure 2). The third isolate (6-1) from the same farm differed from this MRP at only
two locations making the three very closely related.

All other MRPs were deemed

unrelated; differing at six or more locations. Genetic relatedness was also determined by
computer analysis.

Xbal generated band patterns were clustered using UPGMAs of the

Dice coefficients and allowing a 3.0% band position tolerance (Figure 3). Clusters were
seemingly correlated to farm except in the case of ab+ farm #1 isolates which were
grouped into two distinct clusters.

D.

Inserted Cassettes:

cassettes.

lntegron PCR allowed amplification of 14 integrated gene

Direct sequencing of five amplicons revealed the amplified sequence showed

high similarity to aadA (GenBank accession no. AFl 61825), a gene whose product
confers cross-resistance to streptomycin/spectinomycin.

Nine samples that were not

directly sequenced all produced an amplicon the exact size as those that were sequenced.
Moreover, all isolates tested positive by PCR as having aadA gene sequences
downstream of intll gene sequences including two that originally tested negative for the

intll gene (Table 3).
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E. Transformation Results: In each sample, there was a failure to produce strr E. coli
InvaF' through electroporation. Conversely, we were successful in creating Strr InvaF'
through electroporation using the plasmid DNA of control strain #2914. Moreover, we
were successful in re-isolating the 70kb Strr plasmid from transformed isolates. Both the
streptomycin resistant phenotype and the integron genotype of isolate 5-1 were
transferred to the susceptible Salmonella strain through conjugation.
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IV. Discussion
This study detected integron gene sequences rn fecal E. coli isolated from a
variety of healthy swine (i.e. weaning pigs, growers, breeders).

Such isolates are

considered among the normal flora of the swine intestine. Several recent studies allow
for a comparison of our data to that of others. In an examination of multidrug resistant E.

coli isolated from swine, Sunde and Sorem reported that of 134 multi-resistant isolates,
17 were found to carry class I integron gene sequences [26].

Martinez-Freijo and co

workers, however, found a much higher percentage of integron-positive isolates in
clinically important gram-negative samples. In surveying 163 isolates from 14 different
hospital s, 43% of the samples contained class I integron gene sequences [20].
Concurrently, Bass et al. found a higher percentage of integron-positive E. coli in isolates
from di seased birds (36%) [1] . Rosser and Young, however, provided a much more
comprehensive study by examjning 3000 gram-negative isolates taken from an estuarine
environment. Among their samples, only 3.6% were found to carry class I integrons [24).
A comparison of results suggests that class I integrons, like virulence factors, are perhaps
more prevalent in clinically important isolates.
Three of our positive isolates showed amplification of qacEL11 and sulll without
amplification of intll.

Two such isolates tested positive, however, for inti gene

sequences using different primers (i.e. primers that bridge intll and aadA), indicating that
the primer pair specific to intll may not be as sensitive as desired. A small percentage of
isolates (2/16) were found to contain class I integrons that did not contain qacEL11 nor

sull1 gene sequences (non-sulll type class I integrons ).
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The presence of aadA as an inserted cassette in at least 14 of the integron-positive
samples provides evidence contrasting the notion that antibiotic susceptibility return s
upon removal of the drug from the bacterial environment. The gene 's product confers
resistance to streptomycin and spectinomycin exclusively.

While streptomycin is used

by US swi ne producers as a feed additi ve [11 ], neither streptomycin nor spectinom ycin
was used in either set of farms. Similar results have also been reported by European
researchers in countries where streptom yci n and spectinomycin are not used [4] . These
data would indicate that the gene is bei ng conserved in thi s population due to its linkage
to a genetic element necessary for the organisms survival (eg. antiseptic resistance,
sulfonamide resistance).

Such is probably the case with many multiple-drug resistant

isolates and almost certainly the case with sulfonamide resistance in Europe [ 10].
Moreover, it also serves as an indication that among the 70 cassettes commonl y
associated with integro ns, the aadA cassette may be more stabl y integrated as was
postulated by Rosser and Young [24].

A chromosomal location of each integron could

further explain the seeming stability of the gene.
Finally, the disparity in the number of integron-positi ve isolates fo und on farms
that regularl y used antibiotics versus those fa rms that excluded antibi otics warrants
di scussion .

While this study was not designed to detect statistical differences in the

number of positive isolates between the two farm types, there is a visible trend for farms
that include antibiotics to produce more integron-positive bacteria (14.8 %) than farms
that excluded antibiotics (5. 1%) . Moreover, three of four integron containing isolates
obtained from ab- farms proved to be a single clonal strain resulting in only two integron
positive strains of E. coli isolated from the three ab- farms (0.7 strains/farm).
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Conversely, nine distinct strains of integron-positive E. coli were isolated from the four
ab(+) farms (2.25 strains/farm).

Combined with the fact that each ab+ farm had a

different antibiotic management strategy and schedule, these results support the troubling
supposition that antibiotic use, regardless of the type of antibiotic may, in fact, select for
mechani sms that all ow the development of multiple drug resistance.
Interestingly, all int+ isolates were resistant to tetracycline. In successive studies
we have found that tetracycline resistance is correlated with class I integrons even though
tetracycline resistance genes are not known to be formally associated with class I
integro ns. Such an association could partially explain the higher percentage of integron
containing isolates on ab+ farms, as tetracyclines were used in each ab+ in the twelve
months leading up to the study. Similarly, there may be a correlation between integron
positive-isolates and non-specific resistance mechani sms (eg. MAR operon mutation s)
that would cause such organisms to flouri sh in an environment that contained different
types of antibiotics at different times.
It should be noted, however, that the resistant phenotypes were only partiall y
explained by the presence of integrons. All integron positive-isolates, regardless of farm
type, demonstrated resistance to tetracycline. Moreover, several ab+ integron-positive
isolates demonstrated resistance to apramycin, gentamicin, cephalothin, kanamycin ,
sulfamethoxazole/trimethoprim and ampicillin. While several of these phenotypes have
been shown to be correlated to integrated cassettes [15) , in each integron positive isolate,
only streptomycin and sulfanomide resistance were explained solely by the presence of
integrons.
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V. Conclusions
Our study found class I integrons in both E. coli isolated from swine exposed to
antibiotics and E. coli isolated from swine not exposed to antibiotics.

The higher

percentage of integron DNA found in E. coli from ab+ farm s indicates that the use of
antibiotics not only selects for antibiotic resistance genes [ 17] but also may select for the
mechanism by which bacteria develop multiple antibiotic resistance. These data offer
evidence that the type of antibiotic may not be critical in this selection. It follows that the
correlation between int+ isolates and tetracycline resistance deserves further study as
tetracyclines are among the most widely used antibiotics in agriculture [11 , 28].
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TABLE 1. Antibiotic practices of swine farms used as source of E. coli test isolates*.

Antibiotic

Farm 1

Farm 2

1. apramycin

Farm 3

Farm4

ST in creep
feed

ST in weanling to
to 7kg pigs

2. bacitracin

3. carbadox

GP in 77Kg to
to 109Kg pigs
GP in wean-

GP in pigs <

GP in nursery GP in pigs 11-

ling to 14Kg

34 Kg

feed

4. chlortetra- T in 40% finishcycline
mg pigs

18 Kg

GP in all pigs ST in pigs 18and sows
77 Kg

5. lincomycin Tin breeding Tin breeding
stock
stock

GP in pigs 711 Kg and Tin
1-3 day old pigs

6. oxytetra
cycline

Tin sows

Tin sows

7. penicillin

T for growing, Tin sows
finishing, and
breeding stock

8. tylosin

GP in growing
and finishing
pigs

9. vugmiamycm

GP in growing
pigs

10. isoflupredone
acetate

Tin sows

*Table is based on extensive interviews conducted between our laboratory and the
owner/operators of each swine farm [6]; ST= subtherapeutic use; GP= as growth
promotant; T = therapeutic use.
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TABLE 2. Primer pairs used in PCR experiments.

PCR product size (bp)

Name

Sequence

Target

1) s407 (f)

atcagacgtcgtggatgtcg

sul/1

346

int/1

254

qacEiJJ

200

s753 (r)

2) i965 (f)
i1219 (r)

3) q024 (f)
q224 (r)

4) ntf2 (f)
ntr2 (r)

5) ntf2 (f)
antr (r)

cgaagaaccgcacaatctcg

ccttcgaatgctgtaaccgc
acgcccttgagcggaagtatc

gagggctttactaagcttgc
atacctacaaagccccacgc

acaccgtggaaacggatgaag
acegattatgacaacggc gg

acacc gtggaaac ggatgaag
tatcgctgtatggcttcaggc

n/a = not applicable
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integrated gene cassettes

int/1-aadA

405

TABLE 3. Characteristics of integron containing E. coli.

Isolatet

Farm type

Sourcett

Int. type

antibiogram

cassettes

1-1

ab+

240-5-8

2

TGStAp

aadA

1-2

ab+

10-1-3

1*

TSuSt

aadA

1-3

ab+

50-5-4

3

T

uta

1-4

ab+

100-2-6

1*

TStSu

aadA

2-1

ab+

10-4-4

1

TStAm

aadA

3-1

ab+

10-4-8

1

TStSu

aadA

3-2

ab+

100-2-5

1

TSuStCe

aadA

3-3

ab+

100-6-7

1

TSuStK

aadA

3-4

ab+

240-1-4

1

TSuSt

aadA

4-1

ab+

50-5-7

1

TSuCoAmK

uta

4-2

ab+

240-5-6

l*

TSuSt

aadA

4-3

ab+

sow-5-5

2

TSuStK

aadA

5-1 :j:

ab-

100-3-4

1

TSuSt

aadA

6-1

ab-

10-1-3

1

TSuSt

aadA

6-2

ab-

10-4-4

1

TSuSt

aadA

6-3

ab-

10-6-5

1

TSuSt

aadA

tfarm no.-isolate no. ; ab+ = swine farm that include antibiotics; ttpig weight-pig no.isolate no.; ab- = swine farm that exclude antibiotics; 1 = class I sulll-type integron; 2=
class I non-sulll -type integron; 3=tested positive for qacE::11 and sull1 gene sequences
but not intll gene sequences; *=originally tested negative for intll using MP-PCR but
proved positive using intll-aadA PCR; +=isolate transferred resistant phenotype and
integron genotype by conjugation; Am=ampicillin; Ap=apramycin; Ce=cephaJothin;
Co=trimethoprim/sulfamethoxazole; G=gentamicin; K=kanamycin; S t=streptomycin;
T=tetracycline; Su=sulfonamides; uta = unable to amplify.
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Figure 1. PCR amplification of conserved gene sequences of class I integrons.
PCR products separated in 1.5% agarose by conventional electrophoresis and stained
with ethidium bromide for visualization. Lane l = lOObp ladder; integron (+) samples

are: lane 3 = 4-2; lane 4 = 2-1; lane 7 = 3-2; lane 9 = 3-3; lane 11 = blank (negative
control); and lane 12 = Salmonella enterica Typhimurium DT104 (positive control).
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Figure 2. MRPs of E. coli isolates found to possess class I integron gene
sequences. DNA digested with Xbal, separated by pulsed-field gel electrophoresis
and stained with ethidium bromide for visualization. Lane l = £. coli 0157:H7
(reference strain); lane 2 = 6-2; lane 3 = 6-3; Jane 4 = 2-1; lane 5 = 5-1; lane 6 = £.
coli O 157:H7 (reference strain). Photo altered to remove dust.
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70%

80%

90%

I

I

100%

E. coli O I 57:H7 (reference #1 )
E. coli O 157 :H7 (reference #2)
E.coli 0157:H7 (reference #3)
E.coli 0 157:H7 (reference #4)
4-2
4-3
4-1
6-2
6-3
6-1

2- 1
1-1

1-3
3-3
3-2
3-4
1-2
1-4
5-1

Figure 3. Genetic relatedness of E. coli isolates possessing class I
integron gene sequences. Comparisons are made of dice coefficients
of band patterns. An analyzable MRP could not be produced from
isolate 3-1.
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Figure 4. Plasmid profile of Salmonella
transconjugants. Transconjugants the result
of mating with isolate 5-1. Lane 1-2: recipient
plasmid profile prior to conjugation; lanes 3-4:
transconjugant plasmid profile showing
addition of new plasmid; lane 5: negative
transconjugant.
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PART THREE: CHARACTERIZATION OF CLASS I INTEGRONS IN
SALMONELLA SPP. ISOLATED FROM LIVESTOCK, DOMESTIC PETS AND
EXOTIC ANIMALS
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Abstract
In a study exammmg integrons in Salmonella, 30.8% isolates were found to

contain class I integron gene sequences.

The integron-positive isolates represented 15

different serovars and were obtained from nine different animal species. Twenty integron
positive-isolates contained only one integron while 12 were found to contain two
integrons. Of the isolates containing only one integron , each contained an aadA gene
(streptomycin resistance) as an integrated gene cassette. Those isolates containing two
class I integrons contained both aadA and psel (ampicillin resistance) as integrated gene
cassettes.

Antibiotic susceptibility screening of all samples revealed that isolates

containing integrons had a higher frequency of resistance to antibiotics not explained by
an integron gene cassette (tetracycline, chloramphenicol, ampicillin and kanamycin). In
five isolates, the integron and antibiotic resistant phenotype were able to be transferred to
an an tibiotic susceptible recpient by plasmid conjugation. One non-Typhimurium isolate
(var Meleagridi s) di splayed the penta-drug resistant R-type (ACSSuT) common to

Salmonella enterica var Typhimurium DT104.

PCR mapping revealed that the

Meleagridi s isolate contained a DT 104-like Salmonella Genomic Island 1 including the
antibiotic resistance gene cluster. These data suggest that, as with antibiotic resistance,
the presence of class I integron may be high in clinically important bacterial isolates.
Moreover, integron containing isol ates may be more likely to be resistant to several non
integron related antibiotics. Finally, the identification of SGil -like sequences in the low
prevalence serovar Meleagridis, offers further evidence that the island is not limited to
the DT104 strain nor to commonly isolated Salmonella serovars.
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I. Introduction

Coincident with the introduction of antibiotic chemotherapy was the elucidation
that bacteria employ several novel tools to evade the lethal effects of the drugs . It is now
recognized that most clinical cases of antibiotic resistance in bacteria involve horizontal
acquistion of the antibiotic resistant phenotype. It follows that a great deal of research
over the last five decades has focused on the methods by which bacteria acquire DNA
necessary for resistance (for reviews see [l, 20, 29, 36, 49]). Such research has led to the
characterization of several mobile genetic elements, such as conjugative plasmids and
transposons.

Recent studies have shown that many diverse antibiotic resistance genes

are surrounded by conserved DNA sequences.

These conserved sequences, in some

cases, are integrons; genetic mechanisms that allow both the site-specific incorporation of
foreign antibiotic resistance genes and their successful expression (for review see [8, 28,
41]).
Integrons have been found on plasmids, transposons and as independent units on
the bacterial chromosome [7, 22, 23] and, by definition, contain three elements that allow
the incorporation of foreign antibiotic resistance genes: 1) a recombination or attachment
site; 2) an integrase which recognizes recombination sites on both the integron and extra
integron gene cassette; and 3) a strong promoter that allows the expression of integrated
genes [11, 17, 21 , 45] .
Classification of integrons is based on integrase homology and, thus far, four
classes have been described. The integrons most frequently isolated from members of the

Enterobactericeae family, however, belong to class I and aside from a homologous
integrase, usually contain at least three other conserved features:
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1) resistance to

quantenary ammonium (qacEf:.1); 2) resistance to the sulfonamides (sulll); and 3) an
open reading whose function has not yet been identified [21, 23, 41].
Agricultural scientists have taken an interest in integrons due, in large part, to the
dissemination of Salmonella enterica var Typhimurium DT104 (DT104). The DT104
strain has gained notoriety based on its seemingly heightened virulence and a penta-drug
resistant phenotype commonly seen in isolates of the strain (for review see [24]). The
genes responsible for antibiotic resistance have been isolated to a 43kb section of the
DT104 chromosome now termed Salmonella Genomic Island 1 (SGil). On this island
sits a 13kb cluster of antibiotic resistance genes containing two class I integrons whose
gene cassettes confer resistance to streptomycin and ampicillin. Located between the two
integrons are genes conferring resistance to chloramphenicol/florfenicol and tetracycline
[4].

The fact that the DT104 strain was widely isolated from dairies prior to spreading
to the human population has led many researchers and public health officials to blame
both the dissemination and development of the pathogen on the agricultural use of
antibiotics [ 19, 38].

Such a correlation has led to several studies surveying the

prevalence with which other bacteria associated with livestock contain integrons and
determining to what extent their antibiotic resistance phenotypes are integron mediated
[3, 7, 31 33, 51]. In previous studies in our laboratory we have found that integrons are
common among the normal enteric flora of swine (E. coli) and are carried by diverse
bacterial bio-types [14]. The present study examined integrons in various Salmonella
serovars isolated from diseased animals.

This study is unique in that isolates were

obtained from several different species of animal, representing livestock, compamon
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animals, and exotics. Moreover, as one potential health hazard of the agricultural use of
antibiotics is the transmission of antibiotic resistant pathogens from animals to humans
[29, 30], this stud y is unique in measuring the multiple drug resistance development
capacity of a genus which is common in several species of animal and whose subtypes
are all pathogenic to humans [44].
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II. Materials and Methods
A. Sample Isolates: Salmonella isolates (n=l04) were kindly provided by Dr. F. Ann
Draughon of the University of Tennessee Food Safety Center of Excellence (Knoxville,
TN). The following serovars were represented:

Agona (l), Albany (1 ), Anatum (1),

Anjona (1 ), Arizona (5) , Bardo (1 ), Bareilly (1), Bern (1), Berta (1) , Bietri (1) , Bleadon
(1 ), Blackley (1 ), Brandenberg (1 ), California (1 ), Cerro (1 ), Cholerasuis (1 ), Derby (1 ),

Dublin (1 ), Enteriditis (1), Give (l), Hadar (1), Havana (1), Heidelburg (1), Indiana (1) ,
Infanti s (1 ), Istanbul (1) , Java (1 ), Kentucky (1 ), Kintambo (1), Lille (1), Loma-Linda
(1 ), Marina (1 ), Mbdanka ( 1), Meleagradis (1 ), Montevideo (1 ), Muenster ( 1),

Newbrun swick (1) , Newington (1 ), Newport (1) , Oranienburg (1), Parera (1), Pomona
(1 ), Reading (1 ), Rubislaw (1 ), Sachsenwald (1 ), St. Paul (1 ),

Schwartzengrund (1 ),

Senftenberg (1 ), Tennessee (1 ), Thomasville ( l ), Thompson (1 ),

Typhimurium (1 ),

Typhisui s (1) , Waral (1), Weltevrden (2), Widemarsh (!), Uganda (1), 4,5, 12:non-motile
(1) , 4,12 monophasic (1) ,

9,12:non-motile (1) , 45:G ,Z51 (1 ), 47 :D-239 (1) , and

untypeable (1). Those isolates that were only serogrouped represented the following
serogroups: polyA (2) , B (18), polyB (1) , Cl (3), C2 (3), D (3), Dl (1) , E (1), El (4).
Isolates were obtained from 15 different animal species. Isolates were serotyped by Drs.
Rice and Prueitt of the Washington State University School of Veterinary Medicine.
When needed, serovars of isolates were confirmed by the Animal and Plant Health
Inspection Service.

B. Multi-plex PCR (MP-PCR): lntegron harboring isolates were detected using a MP
PCR targeting three conserved sequences of class I integrons (qacE:11 , intl.l and sull.l).
121

Primer pairs were designed using published sequences (GenBank accession no.
AF161825) and manufactured by Operon, Inc. (Alameda, CA) (Table 1).

Total DNA

was prepared by boiling overnight cultures in 2YT broth in an equal volume of 0.2%
(wt/vol) Triton X-100 (Mallinckrodt, Pari s, KY) for five minutes [25]. Boiled cultures
were cooled on ice for 5 min and used immediately for PCR. PCR reagents, excluding
template DNA, were combined in a master mix prior to aliquoting. The final reaction
volumes for each aliquot included: 1) 1 µL of each primer pair (50 pmol [each primer]
µL -1) ; 2) l µL of Taq DNA polymerase (0.5U µL - 1; Promega, Madi son, WI) ; 3) 10 µL
reaction buffer (12.5mM MgC}i, pH 8.5; lnvitrogen, Carlsbad, CA); 4) 5 µL dNTPs
solution (2.5mM of each dNTP, pH 8.0; lnvitrogen); and 5) 32 µL sterile H 20.

Sample

DNA (1 µL) was then added to each aliquot. Reactions were conducted in a Mastercyler
Gradient thermocycler (Eppendorf, Westbury, NJ) with the following cycling: 1) 1 cycle
of 94 °C for 4 min ; 2) 10 "touchdown" cycles of 94 °C for 1 min, 65°C for 30 s
(decreasing 1°C/cycle), 70°C for 2 min ; 3) 24 cycles of 94°C for 1 min, 55°C for 30 s,
70°C for 2 min; and 4) 1 final cycle of 70°C for 5 min.

Salmonella Typhimurium

DT104, known to contain two class I integrons [13], was used as a positive control. A
blank containing only PCR reagents and Triton X-100 was used as a negative control.
Reaction products were separated by gel electrophoresis in 1.5% agarose and stained with
ethidium bromide for visualization.

C. Antibiotic Susceptibility Testing: Each isolate was tested for susceptibility to 18
antibacterials or antibacterial combinations commonly used in human and/or veterinary
medicine (amjkacin, ampicillin, amoxicillin/clavulanic acid, apramycin, cefoxitin,
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ceftiofur,

ceftriaxone,

cephalothin,

chloramphenicol,

ciproflaxacin,

gentamicin,

imipenem, kan amyci n, nalidixic acid, sulfamethoxazole, streptomycin, tetracycline,
trimethoprim/sulfamathoxazole) using the micro-dilution method as outlined m the
protocols of the National Antibiotic Resistance Monitoring System [35].

D. Integron PCR and Cassette Mapping: Integrated gene cassettes were amplified by
PCR using primers specific for the 5' and 3' conserved ends of class I integrons. Primers
were designed using publi shed sequences (GenBank accession no. AF161825) and
purchased from a commercial source (Oligo, Inc., Al ameda, CA) (Table 1).

PCR

reagents, excluding template DNA , were combined in a master mix prior to aliquoting.
Final reaction volumes for each aliquot included: 1) l µL of a primer pair soluti on (50
pmol [each primer] µL -1) ; 2) 1 µL of eLONGase (l.0U µL _,; Life Technologies, Inc. ,
Gaithersburg, MD) ; 3) 10 µL reaction buffer (12.5mM MgC12 , pH 8.5); 4) 5 µL dNTPs
soluti on (2.5 mM of each dNTP, pH 8.0); and 5) 32 µL sterile H 20.
was then added to each aliquot.

Sample DNA (1 µL )

Reacti ons were conducted in a Mastercyler Gradient

thermoc ycler with the foll owing cycling:

1) 1 cycle of 94°C for 4 min ; 2) 10

"touchdown" cycles of 94°C for 1 min, 65 °C for 30 s min (decreasing l °C/cycle), 70°C
for 4 min ; 3) 40 cycles of 94°C for 1 min , 55°C for 30 s, 72°C for 4 min; and 4) 1 final
cycle of 72°C for 5 min.

Salmonella Typhimurium DT104 was used as a positive

control.

Antibiotic susceptible Salmonella T yphimurium #7393 was used as a negative

control.

Inserted gene cassettes were identified through PCR mapping using reaction

parameters described previously.
seque ncing bridging either intll

➔

Reactions were performed using primers targeting

aadA or intll

➔

psel.
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E. DT 104-like Genomic Island Detection PCR: Seven pairs of PCR primers were
designed to amplify linking sequences of the DT104 gene cluster. Three primer pairs
were used to amplify the different left and right SGil junction combinations [4]. Primers
targeting the antibiotic resistance gene cluster were designed using published sequences
(GenBank accession no. AF161825) and purchased from a commercial source (Oligo,
Inc., Alameda, CA) (Table 1).

Primers targeting left and right SGil junctions were

designed as described by Boyd, et al. [4] and purchased from a commercial source
(Oligo, Inc. , Alameda, CA). A map detailing the position of each primer pair in relation
to the full SGil is described (Figure 1). Total DNA was prepared by boiling overnight
cultures in 0.2% Triton X-100 (1:1) for five min . DNA was cooled on ice and used
immediately for PCR.

PCR reagents, excluding template DNA, were combined in a

master mix prior to aliquoting. Final reaction volumes for each aliquot included: 1) 1 µL
of a primer pair solution (l00pmol (each primer) µL -1); 2) 1 µL of Taq DNA polymerase
(0.5U µL -1)( Promega); 3) 10 µL reaction buffer (12.5mM MgC]i, pH 8.5) (Invitrogen) ;
4) 5 µL dNTPs solution (2.5mM of each dNTP, pH 8.0)(Invitrogen) ; and 5) 32 µL sterile
H 20.

One microliter of DNA solution was then added to each aliquot. Reactions were

conducted in a Mastercyler Gradient thermocycler (Eppendorf) with the following
cycling: 1) 1 cycle of 94°C for 4 min; 2) 10 "touchdown" cycles of 94°C for 4 min, 65 °C
for 4 min, 70°C for 4 min; 3) 25 cycles of 94°C for 30s, 55°C for 1 min, 72°C for 2 min ;
and 4) 1 final cycle of 72°C for 5 min . Salmoenella enterica serotype Typhimurium
DT104 #G9086 was used as a positive control.
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Antibiotic susceptible S. var

Typhimurium was used as a negative control.

Reaction products were separated by gel

electrophoresis in 1.5% agarose and stained with ethidium bromide for visualization.

F. Transformation and Conjugation: Attempts were made to transfer integrons and
phenotypic antibiotic resistance markers from integron-containing isolates to an antibiotic
susceptible strain via electroporation and conjugation. For electroporation, samples were
grown overnight in Luria-Bertain (LB) broth containing 32µg/mL streptomycin . Plasmid
DNA was prepared using the lysis in solution method [12]. Plasmid DNA (2 µL) was
combined in solution with 40µL electrocompetent lnva.F'E. coli (Invitrogen). Cells were
transformed using an Electroporator II (lnvitrogen). Transformed cells were resuscitated
in SOC medium and plated on LB agar containing 32µg/mL streptomycin.
In conjugation experiments, both donor and recipient (strs, na!R Salmonella

enterica Typhimurium #4232) were grown separately to reach an O.D.600 = 0.5 . One
milliliter of each donor and recipient was combined in four rnL Luria-Bertani (LB) broth
and liquid mated overnight. Transconjugants were selected by incubating Mueller Hinton
(Difeo, Detroit, MI) agar plates containing 50µg/rnL nalidixic acid and 32µg/rnL
streptomycin with lO0µL of mated culture. Transconjugants were grown overnight in LB
broth and PCR targeting sequences bridging inti1 to aadA was performed using reaction
parameters described previously.

Plasmid DNA was isolated from presumptive

transconjugants as described previously and separated by electrophoresis.

G.

Macrorestriction Profiling (MRPS):

Isolates serogrouped to group B and/or

serotyped to Typhimurium were pulsetyped by macrorestriction profiling to determine
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their genetic relatedness. MRPs were generated by pulsed-field gel electrophoresis PFGE
utilizing the rapid method described by Gau tom [ 17]. One millimeter slices from each
sample plug were di gested in Xbal (Roche Di ag nostics, Indianapolis, IN).

Plugs,

reference strains (Salmonella newport, kindly provided by Barbara Gillespie, University
of Tennessee Food Safety Center of Excellence, Knoxville, TN) and a DT104 control
were separated by PFGE and stained with ethidium bromide for visualization.

MRPs

were visually analyzed and compared usi ng the guidelines of Tenover, et al. [48].

H.

Statistical Analysis:

The frequency of antibiotic resistance in integron-positive

isolates was compared to that of integron-negative isolates usi ng the freq procedure of
SAS [42].

Comparisons were made using the Fisher's two-sided probability tests .

Differences were considered significant at P < 0.05.
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III. Results
A.

PCR Detection of Class I Integrons:

When the pool of isolates (n= 104) was

screened for integron sequences by MP-PCR, a total of 32 (30.8%) class I integrnn
containing isolates were detected . Integron-containing isolates were obtained from 12
different species of animal and represented 20 different serovars and six serogroups
(Table 2). Almost 70% (22/32) of the integron positive isolates, however, belonged to
serogroup B.

Two isolates (435 and 2018) contained non-sulll type class I integrons.

Isolate 435 contained intll gene sequences but was negative for both sulll and qacEiJJ.
Isol ate 2018 contained both intll and qacEiJJ gene sequences but was negative for sulll .

B. Integron PCR and Cassette Determination: PCR was used to determine both the
number of integrons contained in each isolate and types of cassettes contained in each
integron (Figure 2). Integrons of 30 of 32 integron containing isolates were successfully
amplified.

Isol ates 435 and 2018 contained integrons unamplifiable by thi s reaction

presumably due to the absence of reverse primer target sequences. All isolates containing
amplifiable integrons produced amplicons of 1000 bp. Twelve isolates produced both an
amplicon of 1000 bp and an amplicon of 1200 bp. PCR mapping revealed that in each
case, the 1000bp amplicon was amplification of an aadA gene whose product confers
resistance to streptomycin. Because this reaction was amplification from the 5'CS, we
were able to determine that the integrons contained in isolates 435 and 2018 contained
thi s same cassette. PCR also showed that those isolates producing a 1200 bp amplicon
contained an integron with psel as the inserted cassette.

There were no "empty"

integrons. Eleven of the strains containing aadA and psel integrons were reported as
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either serogroup B or serogroup B, serotype Typhimurium. The exception was isolate
5567 which was reported to belong to the E serogroup, Meleagridi s serovar (Table 3).

C. Transformation/Conjugation: In each sample, there was a failure to produce stl
InvaF' through electroporation. Conversely, we were successful in creating strR InvaF'
through electroporation using plasmid DNA of control strain #2914.

Conjugation,

however, proved more successful. Five of 20 isolates tested were able to transfer the strR
phenotype to a susceptible strain (905 , 1878, 2018, 2224 and 1927).

In each case,

integron gene sequences could be amplified from transconjugants and acquired pl asmids
were detected (Figure 3).

D. DT104-like Genomic Island PCR Mapping: Isolate 5567 was originally reported
as belonging to serogroup E. Serotyping by APHIS revealed that the isolate belonged to
the Meleagridi s serovar. As the isolate showed a ACSSuT R-type and contai ned both

aadA and psel integrons, it was of interest to determine if the strain contained any other
DT104-like qualities. A PCR was designed to amplify seven interconnecting segments of
the DT104 antibiotic resistance gene cluster. A second PCR was designed to amplify the
different possible arrangements of SGil left and right junctions. Amplification of isolate
5567 genomic DNA produced posi tive amplicons for each of the seven antibiotic
resistance gene cluster reactions (Figure 4).

Moreover, PCR revealed that the

Meleagridis isolate contained gene sequences indicative of the left and right SGil
junctions as the island appears in DT104 (Figure 5).
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E. Macrorestriction Profiling: Seventeen isolates reported as either belonging to the B
serogroup or the B serogroup, Typhimurium serovar were chosen for macroresistriction
profi ling to determine their clonality and the number of DTl 04 isolates in the set. Isolate
5567 was chosen to determine its genetic relatedness with DT104. Ten isolates produced
macrorestriction profiles indi stinguishable from both the DT104 control strai n and the
standard DT104 pulse-type commonl y seen in our laboratory [13].

Each of the ten

presumptive DT104 isolates contai ned both aadA and psel integron and the penta-drug
resistant phenotype common to the strain . As such, it was determined that the 10 isolates
were of the DT104 strai n. Typhimurium isolate 3182 produced an MRP unrelated to the
DT104 MRP as it differed at over six locations.

Isolate 5567 produced an MRP

di sti nguishable from both 3182 and DT104 MRPs (Figure 6) .

F. Antibiotic Susceptibility Testing and Statistical Comparison:
were screened for susceptibility to 18 antibi otic/antimicrobials.

All test isolates

Several antibiograms

were produced (Table 1). The frequency of resistance was compared between integron
positive and integron-negative isolates to determine any correlation between integrons
and non-integron mediated resistant phenotypes. Using Fisher's two-sided probability
test, it was determined that isolates containing integrons had a stati stically hi gher
incidence of resistance to tetracycl ine, chloramphenicol, and kanam yci n; all phenotypes
that, in these isolates, were not explained by the presence of integrons (Table 4). When
presumptive DT104 isolates were removed from the data set, resistance to tetracycline,
chloramphenicol and kanamycin remained statistically hi gher in integron containing

129

IV. Discussion
The dispute over the prudence of usin g antibiotics in agriculture has continued
without consensus si nce the drugs were discovered to have growth promoting benefits.
The debate has spawned a large number of studies aimed at characterizing mechanisms
by which bacteria acquire antibiotic resistance and also the impact that antibiotic
resistance may have on public health [2, 27, 29, 30, 46].
Along with mobile elements such as conjugative plasmids and transposons, the

integron is recognized as . one mechani sm employed by several bacteri al genera in the
hori zontal acquisition of antibiotic resistance. It is now understood that integrons oversee
the site-specific recombination of several of the genes responsible for antibiotic
resistance. Over 70 distinct gene cassettes conferring resistance to several varied and
diverse classes of antibiotics have been described (for review see [8, 16, 23, 27, 41]).
Researchers have illustrated the prevalence of integron gene sequences m
different types of Escherichia Coli (E. coli) isolated from both diseased [3] and
apparently healthy ani mals [14, 47].

Moreover, integron containing gram-negative

bacteria have been isolated from hospital s [31] and natural aquatic environments [40].
Recently, integron gene sequences have been isolated from gram-positive bacteria [10).
Here we report the widespread prevalence of integrons not only in one [6] but in several

Salmonella serovars, many of them rare. Moreover, the frequency with which they are
found in the wide-ranging serovars is similar to that found by those working with Jess
diverse bacterial populations [3 , 6, 47).

In addition, integron-positive isolates were

obtained from several different species of animal, including exotics, wildlife, domestic
pets and livestock and different sources from each animal (i nternal organs vs. feces, etc.).
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Thus, these data support the notion that integron gene sequences are ubiquitous in several
bacterial populations and the Salmonella genus in particular.
Of interest is the fact that there was very little diversity among the gene cassettes
in our sample set. While our isolates were obtained from a wide ranging set of animals
and exhibited diverse antibiograms, an aadA gene cassette was found as an inserted gene
in each integron-positive sample.

When those isolates exhibiting a DT104 pulsetype

were removed, the aadA cassette was the only cassette found in 20 of 22 remaining
isolates.

Resistance to streptomycin, however, is, unlike many antibiotic resi stant

phenotypes, largely integron mediated [3, 9, 47) . As 46 of 104 (44.2%) isolates in our
sample set were phenotypically resi stant to streptomycin, it would be expected that many
isolates would contain both an integron and a streptomycin resistance gene as its insert.
While ampicillin resistance was also considerable in our sample set (34.6%), resistance to
ampicillin in Salmonella is usually the result of the TEM ~-lactamases whose
corresponding genes are not associated with integrons [5].

As such, it would not be

surprising to find a very low level of integron mediated ampicillin resistance once DTl 04
samples were removed . Such was the case with our sample set. Resistance to other
antibiotics commonly associated with integron gene cassettes (eg. chloramphenicoI,
trimethoprim) in comparison to streptomycin was much lower. Only 13 isolates were
resistant to chloramphenicol and only one isolate was resistant to trimethoprim.

In

neither case was resistance the result of an integron cassette.
More puzzling than the lack of variability in cassettes, however, is the high level
of streptomycin resistance seen in the set of samples, as the therapeutic use of
streptomycin/spectinomycin has declined m both veterinary and human medicine
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medicine [9, 39]. In agreement with others, we believe that the case of streptomycin
resistance could serve as an interesting model in illustrating how antibiotic susceptibility
does not always return upon withdrawal of the antibiotic from the bacterial environment
[9]. It has been argued that the conservation of the strR phenotype within some bacterial
populations is probably due to a genetic linkage of the responsible cassette with one or
more genes that are more necessary for the cell's survival. In the U. S., the argument
could be made using the sulll gene of class I integrons as the likely candidate, as
sulfo namides are still heavily used in both human and veterinary medicine. In Europe,
however, fo llowing the exclusion of streptomycin in both human and veterinary medicine
and the dramatic restrictions on the use of sul fo namides, reports have indicated that the
levels of resistance to both antibacterials have remained comparable to levels when the
dru gs were heavily used [9, 15].

Thus, it would seem that if the conserv ation of the

streptom yci n resistance phenotype is due to the genetic linkage of the gene responsible
with another gene more integral to the cell 's survival, the candidate gene is likel y not
formally part of the integron.
In a similar study performed b y our laboratory exarrunmg integrons m non
hemolytic E. coli isolated from swi ne on farms that included antibiotics versus farms that
excluded antibiotics, it was shown that integrons could be found in both populations and
that streptomycin resistance genes predominated as the integrated cassettes in all
integron-positive samples. Interestingly, there was a considerably higher percentage of
integron-positive samples isolated from farms that regularly used antibiotics.

Neither

streptomycin nor spectinomycin was used on any farm [14, 32]. Such results could imply
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that more integral gene linked to the streptomycin integron is likely another antibiotic
resistance gene.
Indeed, comparing the frequency of antibiotic resistance m integron-positive
versus integron-negative isolates in our data set showed that integron-positive isolates
were statistically more likely to be resistant to, among other drugs, tetracylines. Others
have shown a higher likelihood of multi-resistance, including resistance to quinolones in
integron-positive isolates [3 l]. It could be that the integron (and streptomycin resistance
due to its common presence in integrons) is being conserved due to its linkage to another
antibiotic resistance gene that confers resistance to an antibiotic that is more commonly
present in the bacterial environment (eg. tetracylines). Such a model would imply that
the presence of tetracycline in a bacterial environment could also select for an integron
and thus a multiple drug resistance acquisition mechanism.
Perhaps more troubling is the identification of a DT104-like antibiotic resistance
cluster in a low-prevalence Salmonella serovar. Similar clusters have been identified in
other Typhimurium phage types, serovar Agona [4] and var Paratyphi B [34]. To our
knowledge, this is the first report of a similar gene cluster in the Meleagridis serotype.
Isolate 5567 was obtained from cattle feces in the State of Washington in the year 2000.
Meleagridis outbreaks were documented in 1997 throughout Western North America.
We are unsure as to the connection between the two facts, however, as outbreaks
primarily involved infected sprouts [51].

Moreover, the Meleagridis serotype has been

isolated from wild birds and other objects in a dairy environment [26].

Nevertheless,

the identification of a DT104-like cluster in a new serotype indicates that the cluster is, at
least in part, mobile. Boyd et al. have extensively characterized the 43kb island and the
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antibiotic resistance gene cluster and determined that, like pathogenicity islands, SGil is
surrounded by inverted repeats, which would indicate some type of recombination event.
Moreover, the island contains many cryptic and functional genes associated with mobile
elements (int2 , xis, sex pilus formation) [4].

As others have indicated, the DT104

resistant phenotype can be transduced through P22-like phage ES 18 and PDT 17 which
have been fo und to be released by the DT104 strain [43], illustrating one means by which
the cluster could be disseminated .

As such, there are many factors in and around the

cluster that would indicate its mobility but there has been no consensus as to how this
might occur. Interestingly, isolate 3182, a Typhimurium isolate, also contained an SGi l
element but was deemed unrelated to DT 104. At this time we are unsure of its phage
type.
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V. Conclusions
It should be noted that while there were several diverse antibiograms found in our
sample set, very few resistant phenotypes were integron-mediated. On the contary, only
resistance to streptomycin and/or ampicillin could be attributed to an integrated cassette.
Nevertheless, the high frequency of integron-containing strains in this study
indicates that these genetic structures are common among varied S. enterica serovars.
Moreover, integrons are not limited to isolates obtained from a certain species of animal,
nor distinction , as integron-positive isolates were obtained from livestock, companion
animals and even exotics.

In addition, the DTI 04 antibiotic resistance cluster, once

thought to be indigenous to one clonal strain, has now been identified in at least five
different strains of Salmonella including four different serotypes.

The correlation

between integrons containing streptomycin resistance genes and non-integron mediated
resistance deserves further study and may serve as an interesting model in determining
how antibiotic resistance may evolve and the complexities surrounding the issue at the
molecular level.
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TABLE 1. Primer pairs used in PCR experiments.

PCR product size (bp)

Name

Sequence

Target

1) s407 (f)

atcagacgtcgtggatgtcg

sulll

346

intll

254

qacEill

200

integrated gene cassettes

n/a

int/I- aadA

405

s753 (r)
2) i965 (f)

i1219 (r)
3) q024 (f)
q224 (r)
4) ntf2 (f)
qcr2 (r)
5) ntf2 (f)

cgaagaaccgcacaatctcg
ccttc gaatgctgtaacc gc
ac gcccttgagc ggaagtatc
gagggctttactaagcttgc
atacctacaaagccccacgc
acaccgtggaaacggatgaag
ace gattatgacaac ggc gg
acacc gtggaaac ggatgaag

antr (r)

tatcgctgtatggcttcaggc

6) antf (f)

tcagcccgtcttacttgaagc

qcr2 (r)

ace gattatgacaac ggc gg

7) sulf (f)

ctggtggttatgcactcagc

flor (r)

tattccatc gccagtgaagc g

8) flof (f)

gcctgatagtcagtatcgtcg

tetrr (r)
9) tetrf (f)
tetgr (g)
10) ntf2 (f)

aadA -

qacEil 1

402

sulll -

floR

919

jloR -

tetR

655

tetR -

tetG

550

inti] -

psel

543

gacgcaaatacgctttctctgc
ctcgcttgttctggattagcc
gaatccgaaagctgtccaagc
acacc gtggaaac ggatgaag
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TABLE l. (continued) Primer pairs used in PCR experiments.

Name

Sequence

pser (r)

ttaacgggaagcgctgattgc

11) psef (f)

actacgttcagtattgccggc

qcr2 (r)

accgattatgacaacggcgg

n/a = not applicable
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Target

psel _

PCR product size (bp)

qacE1 I

555

TABLE 2. Sources, serotypes and antibiograms of integron-positive Salmonella isolates.

Strain#

Source

Serogroup

Serovar

Antibiogram

435

avian necropsy

D

Bareilly

CeSSuT

905

avian necropsy

C

Istanbul

AsuT

1854

cheetah necropsy

B

Agona

ACCeKSSuT

1878

rodent necropsy

B

Loma-Linda

SuT

1927

bovine feces

D

Berta

SuT

2018

bovine necropsy

B

4, 12 monphasic

ASSuTK

2224

reptile feces

D

Arizona

SSt

2791

feline necropsy

B

Typhimurium DT104 ACSSuTK

2805

canine aspirate

B

Typhimurium DT104 ACSSuT

2914

opossum necropsy

C

Bern

2959

mink necropsy

B

Typhimurium DT 104 ACSSuT

3098

canine feces

C

Johannesburg

AceSuT

3182

bovine milk

B

Typhimurium

ACCoKSSuT

4467

bovine fly

B

Typhimurium DT104 ACeSuT

4474

bovine fly

B

Typhimurium DT104 ASuTK

4476

bovine fly

D

nt

4494

bovine feces

B

Typhimurium DT104 ACSSuT

4740

bovine feces

B

Typhimurium DT104 ACSSuT

4767

bovine intestine

D

9, 12 non-motile

ASSuT

ACCeSuTK

ACSSUTK
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TABLE 2 (continued). Sources, serotypes and antibiograms of integron-positive

Salmonella isolates

Strain#

Source

Serogroup

Serovar

Antibiogram

5337

bovine feed

B

Havana

SSt

5528

bovine intestine

n/a

untypeable

ASSuTK

5530

bovine feces

B

Typhimurium DT104 CSSuT

5626

bovine feces

B

Typhimurium DT104 ACSSuTK

5567

bovine feces

E

Meleagridis

ACSSuT

5580

bovine fly trap

B

nt

ASuTK

5564

bovine feces

B

nt

ASSuTK

6766

bovine feces

B

Typhimurium DT104 ACSSuT

6560

bovine feces

B

nt

SSu

6681

bovine feces

B

nt

SuT

6901

bovine necropsy

B

Dublin

6846

bovine feed

B

nt

ASuTK

6889

bovine feces

B

Typhimurium

none

AAuAxCFSSuTTi

A=ampicillin; Au=amoxicillin/clavulanic acid; Ax=ceftriaxone; C=chloramphenicol;
Ce=cephalothin; Co=trimethoprim/sulfamethoxazole; F=cefoxitin; K=kanamycin;
S=streptomycin; Su=sulfamethoxazole; T=tetracycline; Ti=ceftiofur; n/a = not
applicable; nt=not tested .
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TABLE 3. Number of integrons, integron sizes and inserted gene cassettes in integron
positive Salmonella isolates.

Isolate

No. Integrons

Integron Sizes(s) (kb)

Inserted Cassette( s)

435

na

na

na

1.0

aadA

905t
1854

1

1.0

aadA

1878t

1

1.0

aadA

1927t

l

1.0

aadA

2108t

1

1.0

aadA

1.0

aadA

2224t
2791*

2

1.0, 1.2

aadA, psel

2805*

2

1.0, 1.2

aadA, psel

2914

na

na

na

2959

2

1.0, 1.2

aadA, psel

3098

1

1.0

aadA

3182

2

1.0, 1.2

aadA, psel

4467*

2

1.0, 1.2

aadA, psel

4474*

2

1.0, l.2

aadA ,psel

4476

1

1.0

aadA

4494*

2

1.0, 1.2

aadA, psel

4740*

2

1.0, 1.2

aadA,psel

149

TABLE 3 (continued).

Number of integrons, inserted gene cassettes and horizontal

transfer potential of resistant phenotype in integron-positive Salmonella isolates.

Isolate

No. Integrons

Integron Sizes(s) (kb)

Inserted Cassette( s)

4767

1.0

aadA

5528

1.0

aadA

5530*

2

1.0, 1.2

aadA, psel

5337

1

1.0

aadA

5567

2

1.0, 1.2

aadA, psel

5580

1

1.0

aadA

1.0

aadA

5564
5626*

2

1.0, 1.2

aadA, psel

6560

na

na

na

6681

1

1.0

aadA

6766*

2

1.0, 1.2

aadA, psel

6846

1

1.0

aadA

6889

1

1.0

aadA

1.0

aadA

6901

na=not amplifiable; *=DT104 isolates, not tested for phenotype transfer; tsuccessfully
transferred both resistant phenotype and integron genotype.
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TABLE 4.
Comparison of the frequency of resistance to chloramphenicol,
tetracycline, sulfamethoxazole, streptomycin, ampicillin and kanamycin between
integron-positive (n=32) and integron-negative (n=72) Salmonella isolates.

Chi

Tet

Smx

Integron (+)

50.0a

87.5a

Integron (-)

7 .0 b

26.8 b

22.5 b

Str

Amp

Kan

Integron (+)

90.6 a

75.0 a

34.4 a

Integron (-)

23.9 b

chl=chloramphenicol;
tet=tctracycline;
smx=s ul famethoxazole;
str=streptomycin ;
amp=ampicillin ; kan=kanamyc in ; co mpari sons made usi ng Fisher's two-sided probability test;
numbers with different superscripts are different at P < 0.01 ; comparisons are within antibiolic.
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TABLE 5.
Comparison of the frequency of resistance
to chloramphenicol,
tetracycline, sulfamethoxazole, streptomycin , ampicillin and kanamycin between
integron-positi ve (n=23) and integron -negative (n=72) Salmonella isolates removing
all DT104.

Chi

Tet

Smx
82.6a

Integron ( +)

34.8a

Integron (-)

7 .0 b

26.8 b

22.5 b

Str

Amp

Kan

Integron (+)

87 .0 a

39.1

Integron (-)

23.9 b

16.9 b

a

c hl=c hl o ramp he nicol; te t= te tracycline ; smx=s ulfame thoxazole; str=streptomyc in ; am p=ampicillin;
kan=kanamycin; compari so ns made usin g Fisher's two-s ided probability test; numbers with different
superscripts a re diffe re nt at P < 0.0 I; comparisons are within antibi oti c.
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Figure 1. PCR map of SGil including the antibiotic resistance gene cluster and the left and right junctions (adapted
from [34]) .
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Figure 2. PCR amplification of integrons and
unknown cassettes. PCR products separated in
agarose by gel electrophoresi s and stained wi th
ethdium bromide for visualization. Lanes 1-10:
integron containing Salmonella isolates; lane 11:
negative control ; lane 12: Salmonella enterica var
Typhimurium DT104 (positive control ).
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A.

B.

Figure 3. Plasmid isolation and PCR reamplification of
integron gene sequence from transconjugants.
A.
Plasmid profile of transconjugants showing new, high
molecular weight plasmid in transconjugants. B . Integron
PCR of tran sconjugants, lane 1: 100 bp DNA marker; Jane
2- lO integron positive transconjugants; lane 11: positive
control ; lane 12: negative control.
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Figure 4.
PCR amplification of
antibiotic resistance gene cluster
sequences in isolate no. 5567. Lane l:
aadA
I00bp DNA marker; lane 2:
qacEL1 1 ; lane 3: sulll-floR ; lane 4: fl oR
tetR ; lane 5: tetR-tetA; lane 6: psel 
qacEL1 1.
intll-aadA and intJJ-psel
amplifications not pictured.
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Figure 5. PCR amplification of left and right junctions of SGil in isolate
no. 5567. A) amplification of left junction, lane I: I 00 bp DNA marker; lane
2-3: isolate 5567; lane 4: negative control ; lanes 5-6: positive control
(DTI 04); B) amplification of right junction (without Typhimurium
retronphage); lane I: 100 bp DNA marker; lane 2-3: isolate 5567; lane 4:
negative control ; lanes 5-6: positive control (DT104); all negative; C)
amplification of left junction (including Typhimurium retronphage), lane 1:
100 bp DNA marker; lane 2-5: isolate 5567; lane 6-9: positive control
(DT104); lane 10: negative control.
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A.

B.

-/
Figure 6. Comparison of Salmonella enterica
var Meleagridis no. 5567 and Salmonella
Xba 1
enterica var Typhimurium pulse-types.
generated DNA fragments separated by pulsed
field gel electrophoresis and stained with ethidium
bromide for visualization. Band pattern differences
in UT5567 are highlighted in red .
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PART FOUR: IDENTIFICATION OF A SALMONELLA ENTER/CA
TYPHIMURIUM DT 104-LIKE SALMONELLA GENOMIC ISLAND 1 IN
SALMONELLA ENTER/CA VAR MELEAGRIDIS
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Abstract
We have identified a Salmonella enterica var DT104-like antibiotic resistance gene
cluster and possibly the entire Salmonella Genomic Island l (SGII) in a strain of

Salmonella enterica var Meleagridis.
cluster included tetR,

The Meleagridis antibiotic resistance gene

tetA and floR gene sequences flanked by aadA and pse l

containing class I integrons.

This strain also contained gene sequences for the left

and right junctions of SGII as they exist in Salmonella enterica var Typhimurium
DT104. Repeated failure to transfer the ACSSuT phenotype to a sensitive host
indicated that the cluster may be chromosomal in location. To our knowledge, this is
the first report of the identification of a DT 104-like genomic island in a low
prevalence Salmonella serovar.
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I. Introduction

Salmonella enterica Typhimurium DT104 is a notorious pathogen due to its
ubiquitous existence in nature and its penta-drug resistant phenotype (R-type
ACSSuT). The ACSSuT R-type is due to the presence of a 13kb cluster of antibiotic
resistance genes located within a 43kb section of chromosomal DNA now termed

Salmonella Genomic Island l (SGil). At opposite ends of the antibiotic resistance
cluster are two class I integrons containing gene cassettes conferring resistance to
streptomycin/spectinomycin and P-lactams (aadA and psel, respectively). Located
between

the

two

integrons

are

genes

conferring

resistance

to

chloramphenicol/florfenicol and tetracycline (jl,o51 and tetA/tetG, respectively) [5, 18].
The molecular characterization of this antibiotic resistance gene cluster has
led to a great deal of research examining the frequency with which other Salmonella
serovars and bacterial genera contain class I integrons, in an attempt to better
understand the epidemiology of resistance genes [3, 6, 13, 15, 20, 24]. While the
individual genes that make up the cluster found in DT104 are not unique, it was
thought until recently that the cluster, and the SGil as a whole, was indigenous to the
DT104 strain [5, 16].

Here we present experimental results that indicate that a

DT104-like antibiotic resistance gene cluster and possibly an entire SGil is present in
a strain of Salmonella enterica var Meleagridis.
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II. Materials and Methods
A. Bacterial Sample: The Salmonella enterica var Meleagridis strain was kindly
provided by Dr. F. Ann Draughon of The University of Tennessee Food Safety
Center of Excellence (KnoxviJJe, TN). Serotyping was confirmed by the Animal and
Plant Health Inspection Service (Ames, IA).

B. Antibiotic Susceptibility Testing: The strain was tested for susceptibility to 18
antibiotics or antibiotic combinations commonly used in either human medicine or
animal production (amikacin , ampicillin, amoxicillin/clavulanic acid, apramycin,
cefoxitin,

ceftiofur,

ceftriaxone,

cephalothin,

chloramphenicol,

ciproflaxacin ,

gentamicin , imipenem , kanamycin , nalidixic acid, sulfamethoxazole, streptomycin ,
tetracycline, trimethoprim/sulfamathoxazole) using the broth dilution method as
described by the National Antibiotic Resistance Monitoring System [17] .

C.

PCR Mapping of SGil-like elelement:

Seven pairs of PCR pnmers were

designed to amplify linking sequences of the DTl 04 gene cluster. Three primer pairs
were used to amplify different possible arrangements of SGil left and right junctions
[5].

Primers targeting the antibiotic resistance gene cluster were designed using

published sequences (GenBank accession no. AF 161825) and purchased from a
commercial source (Oligo, Inc., Alameda, CA). Primers targeting left and right SGil
junctions were designed as described by Boyd, et al. [5] and purchased from a
commercial source (Oligo, Inc., Alameda, CA). A map detailing the position of each
primer pair m relation to the full SGil is described (Figure 1).
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Total DNA was

prepared by boiling an overnight culture (LB) in 0.2% Triton X-100 (Mallinckrodt,
Paris, KY) (l: 1) fo r five minutes. DNA was cooled on ice and used immediately for
PCR. PCR reagents, excluding template DNA, were combined in a master mix prior
to aliquoting. The final reaction volumes for each aliquot included:

I) 1 µL of a

1
primer pair solution ( l00pmol (each primer) µL - ); 2) 1 µL of Taq DNA polymerase

(0.5U µL - 1; Promega, Madison , WI) ; 3) 10 µL reaction buffer (12.5mM MgC1 2, pH
8.5) (lnvitrogen , Carl sbad, CA); 4) 5 µL dNTPs solution (2.5mM of each dNTP, pH
8.0)(lnvitrogen); and 5) 32 µL sterile H20. One microliter of DNA solution was then
added to each aliquot.

Reactions were conducted in a Mastercyler Gradient

thermocycler (Eppendorf, Westbury,

J ) with the following conditions: l ) 1 cycle of

94°C for 4 min ; 2) 10 "touchdown" cycles of 94°C for 4 min, 65 °C for 4 min, 70°C
for 4 min ; 3) 25 cycles of 94°C for 30s, 55°C for 1 min , 72°C for 2 min ; and 4) I
fin al cycle of 72°C for 5 min. Salmoenella en.terica sertoype Typhimurium DT 104
#G9086 , known to harbor two class I integrons [9] , was used as a positive control.
Antibiotic susceptible Salmonella enterica Typhimurium was used as a negative
control.

Reaction products were separated by gel electrophoresis in 1.5 % agarose

and stained with ethidium bromide for visualization.

D. Transfer of Antibiotic Resistance Phenotype: Attempts were made to transfer
phenotypic antibiotic resistance markers from the Meleagridis strain to an antibiotic
susceptible bacterium via electroporation and conjugation.

For electroporation,

samples were grown overnight in (Luria-Bertani) LB broth containing 32 µg/mL
streptom ycin. Plasmid DNA was prepared using the lysis in solution method [8].
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Plasmid DNA (2 µL) was combined in solution with 40 µL electrocompetent Inva.F'
E. coli (Invitrogen). Cells were transformed using an Electroporator II (Invitrogen).

Transformed cell s were resuscitated in SOC medium and plated on LB agar
containing 32 µg/mL streptomyci n. For conjugation, both donor and recipient (str5 ,
nalR Salmonella enterica Typhimurium) were grown separately in LB broth to reach
an O.D.600 = 0.5. One milliliter of each donor and recipient was combined in four
mL LB and liquid mated overnight. Transconjugants were selected by innoculating
Mueller Hinton (Difeo, Detroit, MI) agar plates containing S0µg/mL nalidixic acid
and 32 µg/mL streptomycin with I00µL of mated culture.

E.

Macrorestriction Profiling (MRP):

MRPs of the Meleagridis strain and

Salmonella enterica serotype Typhimurium DT104 were generated and compared by
pulsed-field gel electrophoresis (PFGE) utilizing the rapid method described by
Gau tom [ 10] (Figure 2). One millimeter slices from each sample plug were digested
in Xbal (Roche Diagnostics, Indianapolis, IN). Plugs, reference strains (Salmonella

newport, kindly provided by Barbara Gillespie, U ni versi ty of Tennessee, Knoxville,
TN) were separated by PFGE and stai ned with ethidium bromide for visualization.
MRPs were visually analyzed and compared using the guidelines of Tenover, et al.
[21].
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III. Results and Discussion
A brief description of how this isolate was discovered is warranted.

The

strain was pa1t of a larger pool of Salmonella isolates that tested positive for the
presence of class I inregron gene sequences. In screening integron positive samples
for susceptibility to common antibiotics, it was discovered that the Meleagridis isolate
exhibited a penta-drug resistant phenotype (R type=ACSSuT). When the unknown
integrated cassettes were amplified by PCR for mapping, the Meleagridis isolate
produced two amplicons of equal size as the control strain Salmonella enterica var
Typhimurium DT104 #9086. Noting this trend, we tested the isolate for the presence
of floR gene sequences, a gene found almost exclusively in Typhimurium and DT104
in particular [4], and a positive amplicon was produced (data not shown). With this
knowledge, we developed the PCR mapping strategy described herein to determine if
other genotypic traits indicative of the DT l 04 SGil antibiotic resistance gene cluster
were present in the Meleagridis strain. The Meleagridis isolate was positive for seven
of seven reactions.

A final PCR targeting different left and right SGil junctions

indicated that the junctions existed in the Meleagridis strain as they appear in the
DT104 strain.
To be sure, others have identified the DTI 04 antibiotic resistance cluster
outside the DT104 strain. Boyd et al. have isolated both a Typhimurium PT200 and
an Agona strain containing a DT 104-like antibiotic resistance cluster [5]. A similar
cluster has also been identified in the Parotyphi B serovar [ 16]. Interestingly, the
Agona strain does not contain the Typhimurium retronphage [5].
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Our isolate was obtained from cattle feces in the State of Washington.
Meleagridis outbreaks were documented in 1997 throughout Western North America.
We are unsure as to the connection between the two facts, however, as outbreaks
primarily involved infected sprouts [23].

Moreover, the Meleagridis serotype has

been isolated from wild birds and other objects in a dairy environment [12].
Nevertheless, the identification of a DT104-like cluster in a new serotype indicates
that the cluster is, at least in part, mobile. Boyd and co-workers have extensively
characterized the 43kb island and the antibiotic resistance gene cluster and
determined that, like pathogenicity islands, SGil is surrounded by inverted repeats
which would indicated some type of recombination event.

Moreover, the island

contains many cryptic and functional genes associated with mobile elements (int2,

xis, pilus formation) [5].

As others have indicated, the DTI 04 resistant phenotype

can be transduced through P22-like phage ES 18 and PDTl 7 which have been found
to be released by the DT104 strain [19], illustrating one means by which the cluster
could be disseminated.
The rapid dissemination of DT104 is arguably due, only in part, to its
antibiotic resistance profile. Indeed, several researchers have shown a link between
DT104 infections and increased morbidity and mortality, yet treatment failures,
indicative of the importance of abr in sustaining infection, are rarely reported [11, 22].
Confounding, however, is the fact that research has shown that the strain does not
display heightened invasiveness, increased resistance to hydrogen peroxide nor
increased resistance to reactive nitrogen [1, 7]; all factors that would seemingly aid
the organism in its ability to invade and survive inside host cells. Recent sequencing
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studies, however identified 15 open reading frames to which no function could be
assigned [5].

It will be of interest to see whether over time the functions of these

ORFs are connected to heightened virulence in the strain. It will also be of interest to
see if those strains harboring a DT104-like SGil will share in the both phenotypic
virulence of DT104 and dissiminate accordingly.
DTI 04 virulence may not, however, be the result of a single factor. The strain
does display both a filamentous and rugose phenotype when stressed, is capable of
being aerosolized and shows heightened resistance to heat and acid [2, 11, I 4];
factors that may aid in the survival of the organism between infections and/or in
foodstuffs. Moreover, it may be possible that products of the antibiotic resistance
genes in DT104 are linked to heightened expression of virulence genes not found in
other less common Salmonella serovars as has been found in other strains of bacteria
[24-26]. It is doubtful, however, that any of these factors alone could cause such a
proliferation of the strain. Each factor, however, may not be mutually exclusive. It
may be the case that the combination of factors and the selection pressure of
antibiotics may be greater than the sum of each part.
Nevertheless, the identification of these genomic islands in a low prevalence
serovar clearly demonstrates that the gene cluster is not indigenous to the DT104
strain. It also serves to demonstrate the uncertainties associated with the acquisition
of antibiotic resistance by bacteria and the difficulties in halting its dissemination .
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Abstract
This study measured the prevalence of cl ass I integron gene sequences in Echerichia coli
(E. coli) serogroups that commonly produce Shiga toxins (Stx).

The isolates were

obtained from cattle, human and swine fecal samples. A majority of all isolates tested
(55.4%) were susceptible to 18 major antibacterials or antibacterial combinations
commonly used in human and/or veterinary medicine.

Only 7.3% of the isolates

contained class I integron gene sequences (intll, qacEiJ 1, sulll).

While the integron

positive isolates belonged to serogroups commonly associated with both Stx production
and the development of the hemolytic-uremic syndrome, none of the integron containing
isolates had Stx producing phenotypes. Five integron-containing isolates carried an aadA
gene (streptomycin/spectinomycin resistance) as their sole gene cassette.

One isolate

contained the streptomycin resistance gene aadA7 and orjD, a gene of unknown function.
In comparing antibiotic resistance profiles, there were no differences in the frequency of
antibiotic resistance between Stx producing isolates and non-Stx producing isolates (not
including integron -posi tive samples). 0157 isolates, however, were resistant to nalidixic
acid more frequently than isolates of other serogroups. These data indicate that there is a
low prevalence of both antibiotic resistance and integron carriage in Stx producing E. coli
isolates and confirm the prevalence of aadA genes as integrated gene cassettes.
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I. Introduction
The Shiga toxin (S tx) producing E. coli (STEC) are among the most notorious and
virulent newly emerged pathogens. It is estimated that over 100,000 Americans are
infected with STEC each year.

Di sease symptoms are varied with some infections

producing only mild diarrhea while others result in kidney failure (the hemolytic uremia
syndrome; HUS ). In the worst cases, infections have led to death [23, 24]. Moreover, it
is estimated that the cost of illnesses attributed to STEC infections reac hes over $ 1 billion
each year in the United States alone [11].
STEC first gained notoriety in the early 1980's with two outbreaks of bloody
diarrhea in California. The etiological agent responsible for each outbreak was STEC
O157:H7, which has, over the past two decades, become the classical STEC serotype [23,
41]. To date, however, over 100 distinct E. coli serotypes have been characterized as
STEC [27] and aside from the O157:H7, the serogroups 026, 0103 , 0111, 0128 and
0145 are most often associated with human infections [3] .
Resistance

to

antimicrobials

could

compliment

virulence

attributes

by

contributing to an organism's ability to withstand antimicrobial treatment and/or
environmental selection pressures [l , 14, 18, 19, 28, 37] . In recent years many antibiotic
resistance genes have been isolated to DNA sequences termed integrons; natural
antibiotic resi stance gene traps and expression vectors (for review see ref. [5, 12, 15, 17,
29, 32]).

Integrons have been associated, in many cases, with the development of

multiple-drug resi stance and are regularly isolated from gram-negative bacteria
associated with livestock [2, 4, 20, 31 ].
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The role of antibiotic therapy in human STEC infections is unclear [38, 40].
However, as livestock, and cattle in particular, have been implicated as reservoirs of these
organisms [27], there is a fear that under the selection pressure of an antibiotic, resistant
organisms could be selected for increased growth. It follows that as most human STEC
infections arise from the consumption of contamjnated food products, increasing the
prevalence of STEC among the microflora of a food-producing animal could amplify the
probability that meat and dairy products could become contaminated with the organisms
at collection or slaughter [41].
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II. Materials and Methods

A. Bacterial Isolates: Bacterial isolates were kindly provided by Drs. F. Ann Draughon
and Shelton Murinda of the University of Tennessee Food Safety Center of Excellence
(Knoxville, TN). The isolates represented common Stx producing E. coli serogroups and
included five 0 26 i olates, eleven 055 , seventeen 0111 isolates, eleven 01 28 isolates,
one O 149 isolate and thirty-seven O 157 isolates. Of the 82 isolates, 37 produced stx 1
and/or stx2 proteins [25] . All isolates tested were obtained from dafry cattle, swine or
human fecal samples.

B. Multi-plex PCR (MP-PCR): Integron harboring isolates were detected using an
MP-PCR targeting three conserved sequences of class I integrons (qacELJ J, intll and

sulll). Primer pairs were designed using published sequences (GenBank accession no .
AF161825) and manufactured by Operon, Inc. (Alameda, CA) (Table 1). Total DNA
was prepared by boiling overnight cultures in 2YT broth in an equal volume of 0.2%
(wt/vol) Triton X-100 (Mallinckrodt, Pari s, KY) for five minutes [16]. Boiled cultures
were cooled on ice for 5 min and used immediately for PCR. PCR reagents, excluding
template DNA, were combined in a master mix prior to aJiquoting.

Final reaction

volumes for each aliquot included: 1) 1 µL of each primer pair (50pmol [each primer]
µL-1); 2) 1 µL of Taq DNA polymerase (0.5U µL _,; Promega, Madi son, WI); 3) 10 µL
reaction buffer (12.5mM MgC]i, pH 8.5; Invitrogen, Carl sbad, CA); 4) 5 µL dNTPs
solution (2.5mM of each dNTP, pH 8.0; Invitrogen); and 5) 32 µL sterile H20.

Sample

DNA (1 µL) was then added to each aliquot. Reactions were conducted in a Mastercyler
Gradient thermocycler (Eppendorf, Westbury, NJ) with the following conditions:
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1) 1

cycle of 94°C for 4 min; 2) 10 "touchdown" cycles of 94°C for l min, 65 °C for 30 s
(decreasing 1°C/cycle), 70°C for 2 min ; 3) 24 cycles of 94°C for 1 min, 55°C for 30 s,
70°C for 2 min ; and 4) 1 final cycle of 70°C for 5 min.

Salmonella Typhimurium

DTI 04, known to contain two class I integrons [8] , was used as a positive control. A
blank containing only PCR reagents and Triton X-100 was used as a negative control.
Reaction products were separated by conventional electrophoresis in 1.5 % agarose and
stained with ethidium bromide for visualization. An example of the reaction is shown in
Figure 1.

C. Antibiotic Susceptibility Testing: Each isolate was tested for susceptibility to 18
antibiotics or antibi otic combinations commonly used in ei ther human and/or veterinary
medicine (amikacin, ampici llin , amoxicillin/clavulanic acid, apramycin, cefoxitin,
ceftiofur,

ceftriaxone,

cephalothin ,

chloramphenicol,

ciprofloxacin,

gentamicin,

1m1penem, kanamyci n, nalidixic acid , sul fa methoxazole, streptom yci n, tetracycline,
trimethoprim/sulfamethoxazole) usrng the broth dilution method as described by the
National Antibi otic Resistance Monitoring System [26].

D. Integron PCR and Cassette Mapping: Integrated gene cassettes were amplified by
PCR using primers specific for the 5' and 3' conserved ends of class I integrons. Primers
were designed using published sequences (GenBank accession no. AF161825) (Table 2).
PCR reagents, excluding template DNA, were combined in a master mix prior to
aliquoting. Final reaction volumes for each aliquot included: I) 1 µL of a primer pair
solution (50 pmol [each primer] ~tL -1) ; 2) 1 µL of eLONGase ( LOU µL

-I

Life
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Technologies, Inc ., Gaithersburg, MD); 3) 10 µL reaction buffer (12.5mM MgCb , pH
8.5); 4) 5 µL dNTPs solution (2.5mM of each dNTP, pH 8.0); and 5) 32 µL sterile H 20.
Sample DNA (1 µL) was then added to each aliquot. Reactions were conducted in a
Mastercyler Gradient thermocycler with the foJJowing conditions: 1) 1 cycle of 94°C for
4 min; 2) 10 "touchdown" cycles of 94°C for I min, 65 °C for 30 s (decreasing
1°C/cycle), 70°C for 4 min; 3) 40 cycles of 94°C for 1 min, 55°C for 30 s , 72°C for 4
min ; and 4) l final cycle of 72°C for 5 min. Salmonella Typhimurium DT104 was used
as a positive control.

negative control [8].

Antibiotic susceptible Salmonella Typhimurium was used as a

Amplicons of 1.0 kb have in the experience of this laboratory been

amplificaction of an aadA gene (streptomycin resistance) [9, 10]. As such, aadA inserted
gene cassettes were identified through PCR targeting DNA sequences bridging intll

aadA and using reaction parameters of the MP-PCR.

E. Conjugation: Both donor and recipient (strs, naJR Salmonella enterica Typhimurium
#4232; National Animal Disease Control Center) were grown separately to mid-log phase
(O.D.600 = 0.5). One miJJiliter of each was combined in four mL Luria-Bertani (LB) and
liquid mated overnight at 37°C. Transconjugants were selected by incubating MueJJer
Hinton II (Difeo; Detroit, MI) agar plates containing 50µg/mL nalidixic acid and 32
µg/mL streptomycin with lO0uL of mated culture. Potential transconjugants were grown
overnight in LB and PCR targeting sequences bridging inti 1 to aadA was performed
using the reaction parameters already described.

Plasmid DNA was isolated from

presumptive transconjugants by the lysis in solution method [6] and separated by
electrophoresis.
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F. Statistical Analysis: Antibiotic resistance patterns of STEC vers us non-STEC were
compared using the Frequency procedure of SAS [34]. Comparisons were made using
the Fisher's two-sided probability tests. Differences were significant at P < 0.05.
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III. Results
A. Multiplex PCR: Only 6 of 82 (7.3 %) E. coli were found to contain class I integron
gene sequences (Table 2).

No isolates containing Stx gene sequences contained

integrons. The integron containing islolates were obtained from cattle, humans and swine
(Table 2).

B. Integron Gene Cassettes: Gene cassettes of each integron-containing isolate were
identified through PCR mapping. Integron PCR produced a 1.0kb amplicon in five of the
isolates tested. PCR mapping identified the amplicon in each case as an aadA
(streptomycin/spectinomycin resistance) gene cassette. Similarly, one isolate produced
an amplicon of 1.2kb which was mapped as a combination of aadA7 and orfD (Table 2).

C. Antibiotic Susceptibility Testing: The frequency of resistance to 18 antimicrobials
was tested in both integron-positive and integron -negative isolates.

All integron

containing isolates were resistant to at least two antibiotics (streptomycin and
sulfamethoxazole).

Two integron containing isolates were resistant to three antibiotics.

One integron containing isolate was resistant to two antibiotics. One isolate was resistant
to four antibiotics.

Finally, two integron containing isolates were resistant to six

antibiotics (Table 3).
In contrast, 58.3 % of Stx producing E. coli isolates tested were susceptible to all
antibiotics (Table 4). Among the antibiotic resistant Stx producing isolates, seven were
resistant to one antibiotic, one was resistant to two antibiotics, one was resistant to three
antibiotics and one isolate (isolate 5) was resistant to five different antibiotics.
184

Non-Stx producing, non-integron containing isolates that belong to common Stx
producing serotypes had similar antibiotic resistance phenotypes (Table 5).

Of the non

Stx, non-integron isolates tested, 65.4% were susceptible to all test antibiotics. Five non
Stx, non-integron isolates were resistant to only one antibiotic.

Two non-Stx , non

integron isolates were resistant to three antibiotics while two were resistant to four
antibiotics.

D. Conjugation: In no case was both the resistant phenotype and the integron genotype
of an integron-positive isolate successfully transferred to a susceptible host. Each isolate
was tested twice and while, in some cases, transconjugants were produced, no
transconjugants were found to contain integron gene seq uences as tested by PCR.

E. Statistical Comparison: No integron DNA sequences isolated isolated from Stx
producing E. coli isolates. Conversely, 13 % of non-Stx producing E. coli isolates were
integron-positive.

The low number of integron-positive isolates obtained prevented

reliable comparisons between frequencies of antibiotic resistance rn integron positive
isolates versus integron negative isolates. Overall percentages of resistance of the sample
set are shown in Table 6. No differences in the frequency of antibiotic resistance were
seen in Stx producing isolates versus non-Stx producing isolates (not including integron
positive isolates) (Table 7). Integron-negative isolates belonging to the O 157 serogroup,
however, were more frequently resistant to nalidixic acid than integron-negative isolates
belonging to other serogroups.
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IV. Discussion

STEC infections in humans are responsible for 100 deaths each year in the U. S.
[24].

Most infections manifest themselves as non-bloody diarrhea with abdominal

cramping with some progressing to bloody diarrhea. A small percentage (5 %) of the
most serious infections progress to HUS with children and the immuno-compromised
being most at risk [23, 24].
Shiga toxins are thought to be the main virulence factors in the more serious
complications associated with STEC. There are at least two accessory virulence factors,
however, commonly found in STEC:

1)

intimin, a protein responsible for the

hi stopathologic feature known as attaching-effacing lesion; and 2) enterohemolysin, a
plasmid encoded cytolytic protein [3, 7, 27, 36].
The Shiga toxins themselves represent two immunologicall y unrelated groups of
proteins. Stx 1 is identical to the toxi n produced by Shigella dysenteriae and there is little
variation among E. coli Stx 1 proteins at both the ami no acid and sequence level. Stx2,
however, is thought to be more important in the development of disease in humans and
HUS in particular. Moreover, in contrast to Stxl, 10 different Stx2 gene variants have
been characterized and their corresponding proteins are thought to have different levels of
virulence [30] . Interestingly, both Stx 1 and Stx2 genes are encoded by a bacteriophage
and while Shiga toxins are mostly associated with E. coli and Shigella, recent studies
have isolated Shiga toxin genes in both the Enterobacter and Citrobacter genera [27].
The role of antibiotic therapy in the treatment of STEC infections is unclear.
Reports have indicated that early antibiotic therapy with certain families of drugs can
limit the duration of diarrhea, thereby reducing the period of pathogen shedding and the
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risk of transmjssion [41]. Conversely, researchers have shown that with some antibiotic
families, antibiotic treatment can, as the result of injury to the cell or through induction of
certain phage genes, increase the release of Shiga toxin by the bacterium [38-40].
Regardless of the mechanism, increased release of Shiga toxins could result in an
increased risk of HUS. Many food-producing animals are thought to be reservoirs for
many of the STEC [27] and the powerful selection pressure of antibiotics could result in
increases in the prevalence of STEC in the animal environment if such organisms were to
acquire antibiotic resistance. It follows that an increase in prevalence could translate to
increased contarrunation of food products prior to human consumption [41].
Early examinations of antibiotic resistance in E. coli O 157:H7 indicated that
isolates of this serotype were susceptible to most antibiotics (41]. As 56% of the 0157
isolates in thi s study were susceptible to all antibiotics tested, the data presented here
confirm this finding. There was, however, a higher frequency of resistance to nalidixic
acid among the isolates bel onging to the O 157 serogroups.

We are unaware of other

studies that have reported increased level s of resi stance to nalidixic acid in the 0157
serogroup, thus we are unsure as to the significance of this finding. The high level of
susceptibility to antibiotics outside of nalidixic acid, however, may apply to other
serogroups as the frequency of antibiotic resistance in other serogoups associated with
Shiga toxin production was also low in comparison to surveys examining antibiotic
resistance in generic E. coli isolated from feces [21 , 22].
The prevalence of integron DNA sequences was also low in comparison to similar
studies examining generic types of E. coli. The number of integron containing isolates
was comparable to the level seen in generic E. coli isolated from pigs not exposed to
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antibiotics [9].

Moreover, while integron containing, Stx producing E. coli have been

isolated [41] , the integron containing isolates in our sample set were all non-Stx
producing.

As exposure to some antibiotics has been shown to increase the release of

toxins [38 , 40] , it may be that antimicrobial resistance would present a fitness
di sadvantage to STEC in terms of virulence and thereby prevalence.

In thi s model ,

antibiotics altered by modifying enzymes or driven from the cell by efflux proteins, two
common antibiotic resistance mechani sms, could not induce the genes necessary for
heightened toxin production . Thi s model would be strengthened by data showing that
virulence, and perhaps more specifically, the ability to cause HUS , is a selection factor
among STEC strains.
The fact that all integron-containing isolates included a streptomycin resistance
gene cassette has become somewhat of a running theme in several studies characterizing
integrons in different bacterial populations [2, 9, 10, 35, 41]. Zhao et al. characterized
integrons in a pool of 50 STEC and, similar to the present study, all integron containing
STEC strains contained an aadA gene as the inserted cassette. In contrast to the data
presented here, however, phenotypic resistance markers could be transferred from two
integron containing STEC strains to a susceptible host. Unfortunately, it was not made
clear if these were the only isolates tested or the only isolates that successfully transferred
phenotypic markers [41].

In the present study, conjugation was unsuccessful in all

samples indicating that either the integrons are: 1) part of the bacterial chromosome; 2)
part of a non-conjugative plasmid; or 3) part of a conjugative plasmid that transfers at
frequencies undetectable by our methods.
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V. Conclusions
Results of this study confirm that antibiotic resistance among Stx producing E. coli is
low . Moreover, as integron gene sequences were not detected from any Stx producing
isolates, the capacity for these isolates to acquire integron mediated antibiotic resistance
was also low.

Each of the non-Stx producing, integron-posi tive isolates contained an

aadA gene as an inserted cassette adding proof that thi s gene has become well established
as an integron gene cassette in several bacterial populations.
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TABLE 1. Primer pairs used in PCR experiments.

PCR product size (bp)

Name

Sequence

Target

I) s407 (f)

atcagacgtcgtggatgtcg

sulll 1

346

inti11

254

qacE:1 1

200

integrated gene cassettes

n/a

inti } - aadA

405

s7 53 (r)
2) i965 (f)
i1219 (r)
3) q024 (f)
q224 (r)
4) ntf2 (f)
qcr2 (r)
5) ntf2 (f)
antr (r)

cgaagaacc gcacaatctc g
ccttc gaatgctgtaacc gc
acgcccttgagcggaagtatc
gagggctttactaagcttgc
atacctacaaagccccacgc
acaccgtggaaacggatgaag
accgattatgacaacggcgg
acacc gtggaaac ggatgaag
tatcgctgtatggcttcaggc

n/a=not applicable.
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TABLE 2. Serogroup and genotypic characteristics of integron-positive E. coli isolates.

I solate Serogroup

Source

Stx I

Stx2

2 11 3

O lli

human

no

no

1.0

aadA

2 164

0 128

human

no

no

1.0

aadA

2 166

01 11

human

no

no

1.0

aadA

2168

0 111

human

no

no

1.0

aadA

no. integrons

integrons size(s) inserted cassettes

2 11 9

055

human

no

no

1.0

aadA

2 14 1

0 149

pig

no

no

1.3

aadA + o,fD

Stx=Shiga toxin.

198

TABLE 3. Antibiograms and conjugative traits of integron-positive E. coli isolates.
Isolate No.

Antibiograms

Phenotype transferred?

2113

CSSt

no

2164

ACCoSStT

no

2166

SSt

no

2168

ACKSStT

no

2119

CSSt

no

2141

KSStT

no

A=ampicillin, C=chloramphenicol; Ce=cepholothin; Co=trimethoprim/
sulfamethoxazole; F=cefoxitin; K=kanamycin ; S=sulfamethoxazole;
St=streptomycin; T=tetracycline
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TABLE 4. Serogroups, sources and antibiograms of Shiga-toxin producing E. coli.

Isolate no.

Serogroups

Antibiogram

Source

5

0157

TNSStA

cattle

36

0157

nt

cattle

43

0157

nt

cattle

142

0157

nt

cattle

161

0157

nt

cattle

168

0157

none

cattle

200

0157

none

cattle

203

0157

St

cattle

214

0157

SSt

cattle

268

0157

TNS

cattle

293

0157

Ce

cattle

309

0157

nt

cattle

337

0157

none

cattle

340

0157

none

cattle

368

0157

none

cattle

371

0157

none

cattle

374

0157

F

cattle

384

0157

nt

cattle

386

0157

nt

cattle

400

0157

none

cattle
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TABLE 4 (continued). Serogroups, antibiograms and sources of Shiga-toxin producing
E. coli.

Isolate no.

Serogroup

Antibiogram

Source

424

0157

none

cattle

427

0157

nt

cattle

436

0157

nt

cattle

447

0157

none

cattle

454

0157

N

cattle

456

0157

nt

cattle

457

0157

N

cattle

462

0157

N

cattle

463

0157

none

cattle

583

0157

nt

cattle

2146

0111

none

human

2l49

0111

none

human

2157

026

s

human

2159

026

none

human

2172

0128

none

human

2174

0128

nt

human

2180

0111

nt

human

A=ampicillin; Am=amikacin; C=ch1oramphenico1; Ce=cephalothin;
N=nalidixic acid; S=sulfamethoxazole; St=streptomycin;
St=streptomycin.

F=cefoxitin;
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TABLE 5. Serogroups, antibiograms and sources of non-Shi ga toxin producing, nonintegron containing E. coli isolates.
Sample

Serogroup

Antibiogram

Source

2110

055

none

human

21 l l

055

none

human

2112

055

none

human

2114

055

nt

human

2116

055

none

human

2117

055

nt

human

2130

055

none

human

2131

055

s

human

2133

055

s

human

2134

055

CSStK

human

2135

0111

nt

human

2136

0111

nt

human

2137

0111

s

human

2138

0111

none

human

2148

0111

nt

human

2150

026

none

human

2153

026

none

human

2158

026

nt

human

2160

0128

TSSt

human
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TABLE 5 (contintued).

Serogroups, antibiograms and sources of non-Shiga toxin

producing, non-integron containing E. coli isolates.
Sample

Serogroup

Antibiogram

Source

2161

0128

nt

human

2163

0128

nt

human

2165

0111

nt

human

2167

0111

nt

human

2169

0111

none

human

2170

0128

none

human

2176

0128

none

human

2177

0128

CTSSt

human

2178

0128

nt

human

2179

0128

none

human

2181

0111

K

human

2183

0111

nt

human

2184

0111

none

human

l

0157

TNA

cattle

4

0157

F

cattle

13

0157

none

cattle

133

0157

none

cattle

189

0157

none

cattle

199

0157

none

cattle

222

0157

nt

cattle

A=ampicillin; Am=amikacin; C=chloramphenicol; Ce=cephalothin;
N=nalidixic acid; S=sulfamethoxazole; St=streptomycin;
St=streptomycin.

F=cefoxitin;
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TABLE 6. Percentage of antibiotic resistance in sample E. coli isolates.

A

C

Ce

Co

F

K

Su

S

T

N

Ap

7.1

12.5

1.8

1.8

3.6

7.1

28.6

21.4

12.5

10.7

1.8

a=ampicillin; c=chloramphenicol; ce=cephalothin; co=sulfamethoxazole/trime thoprim;
f=cefoxitin; k=kanamycin; su=sulfamethoxazoJe; s=streptomycin; t=tetracycline;
ap=apramycin; n=50.
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TABLE 7. Percentage of resistance in Shiga toxin vs. non-Shiga toxin producing E. coli.
A
Stx + 4.2
Stx - 3.8

C

Ce

Co

F

K

Su

St

T

N

Ap

0.0
7.7

4.2
0.0

0.0
3.8

4.2
3.8

0.0
7.7

16.7
23.1

12.5
11.5

4.2
] 1.5

20.8
3.8

0.0
3.8

am=ampicillin; c=chloramphenicol; ce=cephalothin; f=cefoxitin; k= kanamycin ; su=
sulfamethoxazole; s=streptomycin ; t=tetracycline; ap=apramycin. Stx+ (n=24); Stx
(n=26).
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Figure 1. MP-PCR of class I integron DNA seq uences. PCR products
separated by electrophoresis in 1.5% agarose and strained with ethidium
bromide for visualization. Lane 1: 100 bp ladder; lane2: qacELJ 1; lane
3: intll ; lane 4 : sulll ; lane 5: MP-PCR of qacELJ J, intll , sulll .
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PART SIX: CONCLUDING REMARKS
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I. Conclusions
At the heart of the controversy surrounding the use of antibiotics in livestock is
the development of antibiotic resistant bacteria.

Bacteria that develop antibiotic

resistance on the farm could negatively affect human health in one of three manners.
First, commensal organi sms could develop antibiotic resistance, infect humans through
the consumption of contaminated food , and transfer resistance phenotypes to human
bacterial pathogens once established among the human bacterial population.

Second,

pathogenic bacteria that transiently infect animals could become resistant and infect
humans through the consumption of contaminated food products. Infections caused by
antibiotic resistant bacteria could lead to prolonged or more serious infections through
treatment failures. Finally, human pathogens that use li vestock as immediate hosts could
develop antibiotic resistance providing them a selection advantage in the presence of an
antibiotic. In this model, antibiotic resistance could lead to increases in the prevalence of
pathogenic organisms among the animal's microflora leading to an increased risk of
contamination of food products.
Research over the past 15 years has shown that antibiotic resistance develops in
many bacterial strains through the use of integron gene capturing systems. The studies
presented here aimed to assess one facet of the health hazards associated with the
agricultural use of antibiotics by characterizing integrons in different bacterial
populations associated with animals. What follows are 1) concluding remarks regarding
the major findings of these studies ; and 2) questions generated by the results of these
studies.
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A.

Integron Prevalence:

In the first experiment, the sample isolates consisted of

generic E. coli isolated from swine both on farms that used antibiotics and farms that
excluded antibi otics.

The experiment was designed to provide a measurement as to the

basal frequency with which generic E. coli could develop integron mediated resistance
with the test isolates serving as a model of organisms that could passively infec t humans
and transfer resistance to more pathogenic organi sms once established in the human
bacterial population. Of 153 test isolates, 16 (10.5 %) were found to contain integron
gene sequences. In separating the two groups of isolates based on their source, 12 of 16
integron-containing isolates were obtained from swine on farms that regularly used
antibiotics. In contrast, only four of 16 integron containing isolates were obtained from
farms that did not use antibiotics.
The second experiment examined the role integro ns play in antibiotic resistance in

Salmonella . The Salmonella isolates were used as a model of a genera of bacteria
pathogenic to humans and commonly found in animals. Antibiotic resistant Salmonella
infection s resulting from consumption of contaminated food products could lead to
prolonged or more complicated infections. The sample set contained a high percentage
of integron containing isolates (30.8% ).

Moreover, the integron containing isolates

represented several different serovars, many of them rare. The results indicate that a high
percentage of Salmonella isolates associated with a wide-range of animals have the
capacity to develop integron-mediated multiple drug resistance.
Similarly, the third experiment examined integrons m E. coli serogroups
commonly associated Shiga-toxin production (STEC). The STEC isolates were used as
models of organisms that, provided the selection advantage of antibiotic resistance, could
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increase in numbers in an antibiotic environment.

Increasing the prevalence of STEC

among the natural microflora could increase the risk that those pathogens could
contaminate food products. In comparison to the results of the two prior experiments,
integrons were found in relatively lower percentages in E. coli serogroups 026, 0 55,
0111, 0128 and 0157. Moreover, integron gene sequences were not found in any Shiga
toxin producing isolates. As several antibiotic families have been found to induce Shiga
toxin production, antibiotic resistance in STEC may not produce the advantage it does for
other bacteria.

B. Streptomycin Resistance: In each experiment, the integron containing isolates were
further characterized and in each case there was a consistent lack of diversity in the types
of gene cassettes. In the first experiment, each integron contained an aadA gene as the
sole integrated gene cassette.

Similarly, when Salmonella enterica var Typhimurium

DTJ 04 isolates were removed from the second sample set, all integron positive isolates
contained only a streptomycin resistance gene as the integrated cassette. Finally, while
no STEC were found to contain integrons, the non-Shiga toxin producing isolates
containing integrons in the sample set all contained a streptomycin resistance gene as the
sole integrated gene cassette.
Several

similar studies

have

shown

that

streptomycin

resistance

genes

predominate as integrated gene cassettes [l, 6 10, 11]. Thus, perhaps more puzzling than
the lack of variability in cassettes, is the high level of streptomycin resistance seen in
bacterial population even though the use of streptomycin in both human and veterinary
medicine has declined [3, 9).
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In agreement with others, we believe the case of

streptomycin resistance could serve as an interesting model to illustrate how antibiotic
susceptibility does not always return following the withdrawal of the antibiotic from the
bacterial environment [3].

It has been argued that the conservation of the strR phenotype

within some bacterial populations is probably due to a genetic linkage of the responsible
cassette with one or more genes that are more necessary for the cell's survival. In the U.
S., the argument could be made using the sull1 gene of class I integrons as the likely
candidate, as sulfonamides are still heavily used in both human and veterinary medicine.
In Europe, however, following the exclusion of streptomycin in both human and
veterinary medicine and the dramatic restrictions on the use of sulfonamides, researchers
have reported that resistance to both the antibacteri als has remained comparable to levels
when the drugs were heavily used [3, 5] . As such , it would seem that if the conservation
of streptomycin resistance phenotype is due to the genetic linkage of the gene responsible
with another gene more integral to the celJ 's survi val, the candidate gene is likel y not
formally part of the integron.
The first experiment examined integrons in non-hemolytic E. coli isolated from
swi ne on farms that included antibiotics versus farms that excluded antibiotics. It was
shown that integrons could be found in both populations and that streptomycin resistance
genes predominated as the integrated cassettes in all integron positive samples.
Interestingly, there was a considerably higher percentage of integron positive samples
isolated from farms that regularly used antibiotics.

Neither streptomycin nor

spectinomycin, however, were among the antibiotics used on any of the farms [4, 7].
Such results could imply that the linkage between the streptomycin integro n and another
more integral gene(s) is, perhaps, with another antibiotic resistance gene.
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Indeed, comparing the frequenc y of antibiotic resistance rn integron positive
versus integron negative isolates in the second experiment showed that integron positive
isolates were statisticall y more likely to be resistant to, among other drugs, tetracylines.
Others have shown a hi gher likelihood of multiple resistance, including resistance to
quinolones, in integron-positi ve isolates [6]. The integron (and streptom ycin resistance
due to its common presence in integrons) could be conserved due to its linkage to another
antibiotic resistance gene that confers resistance to an antibiotic that is more commonly
present in the bacterial environment (eg. tetracylines) . Such a model would imply that
the presence of tetracycline, or perhaps another antibiotic, in a bacteri al environment
could also select for an integron and thus a multiple drug resistance acq ui sition
mechanism.

C. Role of Integrons in Antibiotic Resistant Phenotypes: In most cases, the integron
actually played a small role in the total antibiotic resistant phenotype. In fact, in each
case, only streptomycin resistance and sulfamethoxazole resistance could be directly
attributed to the presence of an integron. While in some cases resistance to these two
drugs made up the entire antibiogram, most integron-positive isolates were resistant to
several other antibiotics not explained by integrons.

D. Salmonella Genomic Island 1-like cluster in Salmonella enterica var Meleagridis:
One of the more interesting findings of these experiments was the identi ficati on of an
SGil -like cluster outside of Salmonella enterica var Typhimurium DT 104.

Similar

clusters have been identified in other Typhimurium phage types, serovar Agona [2] and
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var Paratyphi B [8]. To our knowledge, this is the first report of a similar gene cluster in
the Meleagridis serotype and offers further evidence that the entire DT104 antibiotic
resistanc gene cluster is, through some mechani sm, mobile.

E.

Future Areas of Research:

interesting questions.

The results from these experiments lead to many

Foremost is the possibility of gene linkages between integron

mediated genes and genes whose products confer resistance to other antibiotics. The
correlation between integron carriage and non-integron mediated antibiotic resi stance has
been illustrated by these experiments and experiments of other researchers as well.

The

linkage of integro ns to other antibiotic resistance genes would lead to the model where
the use of one antibiotic could select for organisms that are not only resistant to the
specific drug but also contain the integron gene capturing system. An additional stud y
should attempt to characterize these linkages at the molecular level.
Another interesting area of research could examine the role of integrons in
genome evolution.

The functions of several of the integron gene cassettes thus far

sequenced have not been characterized.

Indeed, several integron containing isolates

characterized by thi s laboratory but not included in these experiments were found to
contain unidentified open-reading frames as the inserted cassette . The unidentified open
reading frames do not, however, appear to function in antibiotic resistance.

It would be

interesting to elucidate that the genes encode for less adaptive functions than antibiotic
resistance as is the case with the gene cassettes of the super-integrons.

It could be

discovered that integrons are not only associated with antibiotic resistance development
but perhaps, toxin or even housekeeping gene acquisition.
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F. Final Words: The use of integrons in the development of antibiotic resistance is one
method used by bacteria to adapt to harsh environments. Data presented herein confirm
the importance of the integron gene capturing system in bacterial adaption by showing
their ubiquity in several bacterial populations important to both animal and human health.
Moreover, as correlations between integrons and non-integron mediated resistance were
shown in several cases, it may be that integrons often work in concert with other genetic
factors to produce multiple-drug resistant phenotypes. Finally, these data offer further
evidence that the antibiotic resistance cluster of Salmonella enterica Typhimurium var
DT I 04, a major impetus for much of the integron research in agriculture, is present in
other Salmonella strains.
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" ... When you want genuine music - music that will come right home to you like a bad
quarter, suffuse your system like strychnine whiskey, go right through you like
Brandeth's pills, ramify your whole constitution like measles, and break out on your hide
like pin-feather pimples on a pickled goose - when you want all thi s, just smas h your
piano, and invoke the glory-beaming banjo!"
-Mark Twain, 1865
"We consider that the man who can fiddle all through one of those Virginia reel s without
losing hi s grip, may be depended upon in any kind of emergency."
-Mark Twain, 1863

5540 8765 27 rl
218

111/13/83

~ IIIJ

'

